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ABSTRACT 
Left ventricular (LV) remodeling is nominally an adaptive process that restores 
biomechanical function following myocardial injury and/or sustained alterations in loading 
conditions. This remodeling can materialize as changes in myocardial geometry, 
composition, and mechanical properties. When these changes fail to restore LV 
biomechanical function, remodeling is termed maladaptive. It is generally accepted that 
maladaptive LV remodeling underlies the progression to heart failure in various forms of 
heart disease. The central hypothesis of this study is that we can leverage 
echocardiographic imaging techniques to non-invasively quantify changes in 
biomechanical function and mechanical properties in a serial manner throughout the 
progression towards heart failure. The corollary to this hypothesis is that the observed 
changes in function and mechanical properties can, at least in part, be attributed to a 
reorganization of collagen within the extracellular matrix. Large animal models of 
myocardial infarction and left ventricular pressure overload were integrated with 
echocardiographic imaging, computational modeling, and multi-photon microscopy to test 
this hypothesis. We posit that this delineation of disease-specific LV remodeling outcomes, 
with focus on regional mechanical changes throughout the myocardium, will promote 
translational strategies that can interrupt this deterministic process. 
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CHAPTER 1 
INTRODUCTION – MECHANOBIOLOGY OF THE HEART 
1.1 BASIC ANATOMY AND PHYSIOLOGY 
The heart, a muscular organ located in the center of the thoracic cavity, will beat 
up to 10,000 times in a single day or three billion times over the average lifespan of a 
human. The primary function of the heart is to serve as the pump in the cardiovascular 
system which is responsible for delivering oxygen-rich blood and nutrients to every cell in 
the body via the vascular network of arteries and veins. This circulation of blood is vital to 
sustaining life. 
1.1.1 The Four Chambers of the Heart 
The internal anatomy of the heart reveals four chambers composed of cardiac 
muscle (Figure 1.1). The four chambers of the heart are separated into two halves by a 
central wall, the septum. Each half of the heart functions as an independent pump that 
consists of an atrium and a ventricle. The atria receive incoming blood from the venous 
system and the ventricles propel the blood through the arterial system in a continuous loop 
(Figure 1.2). The key function of the right side of the heart is to receive unoxygenated 
blood from the entire body and deliver it through the pulmonary circulatory system to the 
lungs for oxygenation. Once the oxygenated blood returns to the heart through the left 
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atrium, it is then actively pumped through to the entire body via the mechanical force 
resulting from the contraction of the left ventricular myocardium. 
The major blood vessels emerge from the base of the heart. The inferior and 
superior vena cava terminate at the right atrium to return blood to the heart from the rest of 
the body. The pulmonary trunk, or pulmonary artery, delivers blood to the lungs from the 
right ventricle. Oxygenated blood returns to the heart from the lungs via the pulmonary 
vein at the left atrium. Finally, blood is delivered from the left ventricle to the rest of the 
body first through the ascending aorta. Superficially on the surface of each of the ventricles 
is a network of coronary arteries and veins which supply blood to and from the heart muscle 
itself. The left anterior descending artery and the left circumflex artery deliver the vast 
majority of the oxygenated blood to the left ventricular myocardium so as to ensure it can 
function properly as a pump. 
The flow of blood through the heart is unidirectional. This is made possible by two 
sets of valves which prevent the backward flow of blood. Between each atrium and 
ventricle is an atrioventricular valve. These thin flaps of tissue are attached to the base of 
the atrioventricular union by a ring of connective tissue. The ends of the valves on the 
ventricular side are attached to collagenous tendons, the chordae tendineae. These chordae 
tendineae terminate inside the ventricles at a muscle mass called the papillary muscle. 
While this papillary muscle plays no role in the opening of the valves, its primary function 
is to stabilize the valves and prevent inversion during ventricular contraction. While similar 
in function, the two atrioventricular valves are not identical. The valve separating the right 
atrium and right ventricle is called the tricuspid valve in reference to its three distinct flaps. 
Alternatively, the atrioventricular valve separating the left atrium and left ventricle only 
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has two flaps and is accordingly called the bicuspid valve. This bicuspid valve is more 
commonly referred to as the mitral valve in reference to its resemblance to the tall 
headdress worn by bishops and senior clergy, a miter. Distal to each of the two ventricles 
is a semilunar valve preventing the backflow of blood from the arteries to the ventricles. 
Each semilunar valve has three cuplike leaflets which snap closed when the pressure inside 
of the ventricle drops during ventricular relaxation. 
1.1.2 Composition of the Heart 
The heart is encased in a tough membranous sac known as the pericardium. The 
pericardium is attached to the diaphragm and is filled with pericardial fluid that protects 
the heart and functions similarly to a lubricant. Additionally, this pericardial sac limits the 
rigid body motion of the heart. The outermost layer of the heart itself is primarily composed 
of collagenous matrix with some embedded elastic fibers. A cross-section of the heart 
reveals that there are two additional layers, the middle myocardium and a deep lining called 
the endocardium. The endocardium is a thin sheet of epithelium that lines the heart and 
constitutes the valves of the heart. On the other hand, contractile cardiac myocytes make 
up the bulk of the myocardium and are generally 120 µm long and 20-30 µm in diameter. 
These cardiac myocytes are arranged in a locally parallel manner and are embedded in an 
extracellular matrix consisting primarily of collagen. While relatively parallel on a local 
level, the myocytes are arranged in a spiraled helix that varies transmurally from the 
endocardium to the epicardium such that the cardiac myocytes can generate sufficient force 
to direct the proper flow of blood through the cardiovascular system. 
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1.1.3 Contraction of the Heart 
Much like skeletal muscle, cardiac muscle is excitable and can generate an action 
potential. Unlike an innervated skeletal muscle, however, the signal for contraction is 
generated by specialized non-contractile cardiac cells called autorhythmic cells. These 
autorhythmic cells are commonly referred to as the pacemaker cells. These autorhythmic 
cells have an unstable membrane potential which begins at -60 mV and gradually becomes 
less negative until it reaches a threshold and ultimately triggers an action potential. This 
action potential, originated by the pacemaker cells in the sinoatrial and atrioventricular 
nodes, is conducted to the contractile cardiac myocytes. This electrical signal is then 
converted to a mechanical response (i.e. contraction of the muscle) through a process called 
excitation-contraction coupling. In this process, calcium ions from the sarcoplasmic 
reticulum and the extracellular fluid are released and then bind to troponin – thereby 
initiating the formation of actin-myosin cross-bridges and the contraction of the cell 
1.1.4 The Cardiac Cycle 
The cardiac cycle is the sequence of rhythmic events including the contraction and 
relaxation of each of the four chambers of the heart to pump blood through the 
cardiovascular system. The beginning of the cardiac cycle is commonly marked with the 
brief moment at which all four chambers are relaxing. In this moment, the atria are filling 
with blood from the veins. Meanwhile, active ventricular ejection has just been completed. 
Subsequently, the atrioventricular valves open and blood is passively transferred to the 
ventricles down the hydrostatic pressure gradient with the assistance of gravity. The final 
twenty percent of ventricular filling is accomplished as the atria contract and forcibly eject 
into the ventricles. Ventricular systole then begins and the rapid elevation in pressure 
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pushes against the underside of the atrioventricular valves and forces them closed so that 
blood does not flow back in the atria. With both the atrioventricular and semilunar valves 
closed, the cardiomyocytes of the left ventricle continue to contract in what is referred to 
as isovolumic ventricular contraction. Subsequently, the resultant generation of pressure 
forces the semilunar valves to open and the blood is pushed in to the arteries. This is 
referred to as ventricular ejection. The force generated by this ventricular contraction 
becomes the driving force for blood flow. The high-pressure blood forced in to the arteries 
then displaces the stagnant low-pressure blood and forces that blood further into the 
vasculature. At the end of ventricular ejection, the ventricles begin to relax, and 
intraventricular pressure is reduced. Once the pressure in the arteries exceeds that of the 
ventricle, the semilunar valves are forced shut by the backflow of blood from the arteries. 
While the ventricles relax and the intraventricular pressure continues to fall, isovolumic 
ventricular relaxation occurs. Once the atrial pressure exceeds that of the ventricle, the 
atrioventricular valves open and initiate the beginning of the next cardiac cycle. This 
process is summarized in the widely-accepted Wigger’s Diagram (Figure 1.3) which 
illustrates the coordination of cardiac events and the resultant relationships between 
hydrostatic pressure, chamber volumes, and electrical impulses. The entire cardiac cycle is 
customarily simplified into two distinct phases: systole and diastole. In the left ventricle, 
the onset of systole is conventionally defined as the time of the mitral valve closure or the 
by the peak of the QRS complex (i.e. R) on the electrocardiographic signal. The end of 
systole and the subsequent onset of diastole is conventionally defined as the end of 
ventricular ejection. Finally, diastole is used to define the entire ventricular filling phase. 
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1.2 CLINICAL EVALUATION OF HEART STRUCTURE AND FUNCTION 
Given the vital importance of the function of the heart to sustaining life, there is an 
obvious need for techniques that allow for the measurement of the myriad of geometric 
and functional parameters of the heart in a clinical setting. Advancements in both hardware 
and software over the years have given rise to a variety of clinically-translatable modalities 
for this very purpose. 
1.2.1 Echocardiography 
At present, echocardiography is the most clinically-accessible modality to assess 
the structure and function of the heart.1 In short, echocardiography uses ultrasonic waves, 
in the order of MHz, to provide a real-time image of the beating heart. The ultrasonic beam 
is produced by a transducer probe and directed towards the region of interest using a 
transthoracic or transesophageal approach. As the sound waves are intersected by tissues 
with varying densities, these sound waves are reflected back on the transducer. The 
detected backscatter will be higher in magnitude for tissues with a higher density. The real-
time processing of this backscatter on the ultrasound device allows for a non-invasive 
bedside visualization of the structure and function of the heart. 
Current guidelines for the clinical use of echocardiography reveal that the most 
common use-case for echocardiography is for the assessment of left ventricular (LV) 
systolic function and diastolic function.2 The most commonly reported quantitative 
measure of global LV systolic function is the ejection fraction (EF) defined as 
𝐸𝐹 =
𝑉𝐸𝐷−𝑉𝐸𝑆
𝑉𝐸𝐷
× 100%. (1.1) 
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This measurement of EF is reliant on the measurements of LV volumes at end diastole 
(𝑉𝐸𝐷) and end systole (𝑉𝐸𝑆) determined most commonly from Simpson’s biplane method 
of disks.3 Along with LV EF and volumes, echocardiography also allows for the 
quantification of LV internal diameters and wall thicknesses. These measurements give 
rise to an estimation of LV mass originally proposed by Devereux et al in 1986 of the form 
𝐿𝑉 𝑚𝑎𝑠𝑠 = 0.8{1.04[([𝐿𝑉𝐸𝐷𝐷 + 𝐼𝑉𝑆𝑑 + 𝑃𝑊𝑑]3 − 𝐿𝑉𝐸𝐷𝐷3)]} + 0.6, (1.2) 
where LVEDD, IVSd, and PWd represent LV, intraventricular septal, and posterior wall 
thickness at end diastole, respectively.4  
Going beyond measures of structure and function derived from geometric 
measurements, Doppler principles have been applied to echocardiographic analysis to 
allow for quantitative measurements of the hemodynamics in the heart to evaluate global 
diastolic function.5 The phenomena first observed by Doppler in the 19th century was that 
the frequency of a wave can be altered by a moving target acting as interference. In regard 
to its applicability to cardiac evaluation, the ultrasonic waves emitted by the 
echocardiographic probe are altered by the movement of red blood cells in such a way that 
we can derive a complete picture of the cardiac flow field from an analysis of the detected 
backscatter. Furthermore, the emitted frequency can be tuned for different applications. A 
pulse-wave Doppler analysis has a high spatial resolution but encounters error when 
measuring high-velocity flow. Meanwhile, continuous-wave Doppler excels at accurately 
detecting high-velocity flow, but only flow in the direct line of the emitted signal.6 While 
most commonly applied to fluid analysis, the same principles can also be applied to 
structural analysis where the tissue serves as the interference for the frequency rather than 
the red blood cells. Through a combinatorial approach of both fluid Doppler and tissue 
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Doppler, we can measure mean pulmonary capillary wedge pressure (PCWP), an indirect 
estimate of LV diastolic pressure, using the techniques first proposed by Nagueh et al in 
1997 of the form 
𝑃𝐶𝑊𝑃 = 1.91 + 1.24 ×
𝐸
𝐸𝑎
, (1.3) 
where 𝐸 is the peak transmitral flow velocity of early left ventricular filling and 𝐸𝑎 is the 
velocity of the movement of the mitral annulus at the lateral site early in diastole. 
The most recent advancement to be applied to echocardiographic analysis of the 
heart is that of strain imaging through speckle tracking echocardiography (STE). An early 
study by Leitman et al in 2004 laid the groundwork for this technology with the initial 
observation that intrinsic acoustic markers in the myocardium, or speckles, visible in 
echocardiographic images were stable throughout the cardiac cycle.7 With this observation, 
a tracking algorithm was developed to track the movement of the spatial mesh of acoustic 
markers throughout the cardiac cycle to allow for an accurate measurement of strain in the 
myocardium. Measurements of segmental strain (ε) are calculated as 
𝜀 =
𝐿−𝐿0
𝐿0
=
∆𝐿
𝐿0
 , (1.4) 
where 𝐿 is the length of a particular myocardial segment and 𝐿0 is the length of that segment 
at end diastole. Over the years, this quantitative technique has been applied with increasing 
regularity for both global and regional analysis of left ventricular function and mechanical 
behavior.8 The utilization of different echocardiographic views makes it possible to 
determine the full field of LV strain in the circumferential, longitudinal, and radial 
directions.  
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1.2.2 Cardiac Magnetic Resonance Imaging 
While echocardiographic analysis is certainly more clinically-accessible, the long-
heralded gold standard for the evaluation of cardiac structure and function is cardiac 
magnet resonance imaging (cMRI). The most prominent advantage that cMRI has over 
echocardiography is that it is not limited to acoustic windows. The quality of an 
echocardiographic image varies greatly depending on factors such as anatomical 
interference (e.g. the location of the lungs) or the degree of obesity of an individual patient. 
The magnetic field applied in cMRI applications can penetrate through these interferences 
and capture the entirety of the heart. Furthermore, the application of techniques such as 
cMRI tagging allows for high-fidelity measurements of deformation throughout the 
heart.9,10 Nevertheless, the high cost and long examinations times has severely limited the 
clinical use of cMRI for the assessment of cardiac structure and function.11   
 
1.3 MECHANICAL ASSESSMENT OF THE HEART 
Under normal and pathological conditions, the function of the heart is governed and 
regulated by the underlying mechanics of both the structure and the myocardium. Broadly 
speaking, mechanics refers to the relationship between the forces applied to an object and 
the translation, rotation, and deformation resulting from these applied forces. In the living 
heart, the total mechanical behavior would be defined as the sum of both the active 
mechanics resulting from the contractile cardiac myocyte and the passive mechanics of the 
completely relaxed myocardium. While there is interrelation between these two forces, for 
the purposes of this review, we focus only on the passive mechanics of the myocardium.  
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An understanding of the relationship between the passive mechanical properties of the 
heart and their effect on function is the central goal of cardiac mechanics research. 
1.3.1 Benchtop (ex-vivo) Analysis 
The majority of the early work characterizing the mechanics of the passive 
myocardium came from uniaxial tests on excised pieces of cardiac tissue.12,13 Despite the 
significance of this early work, further investigation into the locally heterogeneous 
structure of the myocardium gave rise to a need to move beyond an assumption of isotropic 
behavior. To that end, studies using biaxial test setups would later show that the passive 
myocardium exhibits an anisotropic behavior that varies from region to region.14 This work 
gave rise to a “golden-era” of cardiac mechanics research from 1980-2000 where a number 
of constitutive models were developed to link the states of stress and strain in the passive 
myocardium.15–20 Further work was completed by Zile and colleagues to isolate the cardiac 
myocyte and perform tensile testing and eventually define constitutive relations for the 
isolated myocyte. While there is clear value in these monumental studies, no one 
experiment is comprehensive. It must be considered that the excision of these tissues 
influences hormonal factors and control of the nervous system and ultimately the properties 
of the cardiac myocytes, the myocardium, and the heart as a whole. 
1.3.2 Clinical (in-vivo) Analysis 
Technological advancements over the last few decades have made it possible to 
perform mechanical analysis for clinical research. One of the most important advancements 
in that time was the advent of sensitive cardiac catheters for the measurement of 
intraventricular pressures. The use of these catheters along with image modalities such as 
angiography or echocardiography allowed for detailed analysis of the relationship between 
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pressure and volume throughout the cardiac cycle. Early work by Mirsky and 
Pasipoularides laid the foundation for this work.21,22 They first introduced the concept of 
calculating an index of LV chamber stiffness of the form 
𝑃 = 𝑃0𝑒
𝐾𝐶
𝑉
𝑉𝑊, (1.5) 
where 𝑃 is the intraventricular pressure, 𝑃0 is a fitting parameter, 𝐾𝐶 is the chamber 
stiffness, 𝑉 is the volume of the ventricular chamber, and 𝑉𝑊 is the volume of the wall. 
This measurement of chamber stiffness, a structural index that is a function of geometry 
and local material properties, has proven to be a valuable index of diastolic function.23 On 
a local level, Janz introduced a method by which to quantify local myocardial wall stress 
𝜎 =
𝑃𝑟2
2𝑡(𝑠𝑖𝑛𝜃)(𝑟+
𝑡(𝑠𝑖𝑛𝜃)
2
)
, (1.6) 
where 𝑃 is the intraventricular pressure, 𝑟 is the local radius, 𝑡 is the local thickness, and 𝜃 
is angle between the normal vector from the endocardium at the region of interest and the 
axis of revolution in the truncated ellipsoid model.24 Since then, the major push in the in-
vivo analysis of cardiac mechanics has come by way of advanced finite element analysis. 
The work by Costa, Wenk, and others of the normal and diseased heart serves as 
demonstration that detailed biomechanical analysis using computational tools is feasible, 
albeit at the cost of computational time, the need for expert analysis, and expensive 
hardware resources.25–29 There is a clear need for this type of technology to be made more 
clinically accessible and practical for the routine analysis of cardiac mechanical function. 
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1.4 HEART FAILURE – ONE SYNDROME WITH MULTIPLE ETIOLOGIES 
1.4.1 Clinical Relevance 
An all-too-common pathway for a host of cardiac disorders is a progression towards 
heart failure. Heart failure is a complex clinical syndrome that can result from any 
structural or functional cardiac disorder that impairs the ability of the ventricle to fill with 
or eject blood. The rate and incidence of the development and progression of heart failure 
continues to escalate, and recent statistics have identified this disease as the leading cause 
of morbidity and mortality – eclipsing all other chronic diseases.30 While significant 
progress has been achieved in the therapeutic management of other major illnesses such as 
cancer, these advancements have not been forthcoming for heart failure. One likely reason 
for this is that, unlike cancer which is classified by morphology, cell type, and 
molecular/genetic profiles, heart failure has been historically considered as a single entity. 
However, it has become recognized that distinctly different etiologies for the presentation 
of these heart failure symptoms exist, which, in turn, have demonstrated distinctly different 
therapeutic responses and clinical outcomes.31 A recent consensus has emerged that a 
generalized dichotomy can be made for the classification of heart failure through the 
evaluation of LV EF.32 Specifically, heart failure patients presenting with a LV EF below 
45% would be classified as heart failure with reduced ejection fraction (HFrEF). 
Alternatively, those heart failure patients with a normal LV EF (i.e. greater than 45%) 
would be classified as heart failure with preserved ejection fraction (HFpEF). It has been 
found that the prevalence of these two phenotypes of heart failure is equally distributed.31 
Furthermore, long-term morbidity and mortality rates between the two phenotypes are 
virtually indistinguishable.33 Ultimately, these trends warrant further investigation so as to 
  
13 
 
delineate the pathophysiological mechanisms which give rise to each phenotype of heart 
failure (Table 1.1). Though the progression to heart failure is unequivocally multi-factorial 
in nature, the changes associated with both types of heart failure can be attributed to the 
cumulative alterations in geometry, composition, and function; defined as remodeling. 
1.4.2 Systolic Heart Failure (HFrEF) 
Systolic heart failure, commonly referred to as HFrEF, is a clinical syndrome 
characterized by a dilation of the left ventricle and impaired systolic pump function. HFrEF 
is an all-too-common sequela of myocardial infarction (MI). A MI occurs secondary to an 
acute coronary event which functionally cuts off the flow of oxygen-rich blood to the area 
of the myocardium supplied by that vessel. This local ischemia results in cardiac myocyte 
death and the development of a non-viable and fibrotic scar.34 In the days and weeks that 
follow this acute event, there are progressive changes in the LV geometry on a global (e.g. 
increased end-diastolic volume) and local (e.g. thinning within the MI region and 
hypertrophy of the viable remote region) scale.35–41 Critically, these structural 
abnormalities have a detrimental effect on the systolic function of the LV. This systolic 
dysfunction becomes apparent through an analysis of LV EF as it commonly falls below 
45%.42 This fall in EF can be attributed to several factors such as severe dilation of the LV, 
a high prevalence of non-viable myocardium, and changes in the passive mechanical 
properties of both the MI region and the remote myocardium.41,43,44 Ultimately, the 
inability to meet the metabolic demands of the body through normal pump function  gives 
rise to the presentation of the signs and symptoms of HFrEF. 
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1.4.3 Diastolic Heart Failure (HFpEF) 
Diastolic heart failure, commonly referred to as HFpEF, is a clinical syndrome 
characterized by a presentation of the signs and symptoms of heart failure, abnormal 
diastolic function, and a preserved ejection fraction. Conceptually, HFpEF occurs when 
the LV chamber compliance is reduced to the point at which it can no longer accept an 
adequate volume of blood during the diastolic filling phase. This type of heart failure 
commonly results from an exposure to a prolonged LV pressure overload such as aortic 
stenosis.45 HFpEF that occurs secondary to LV pressure overload results in a thick, 
hypertrophied, left ventricle. Furthermore, this disease is coincident with the presentation 
of abnormal active relaxation. This phenomena becomes apparent through the 
echocardiographic observation of either a prolonged isovolumic relaxation phase or 
delayed active relaxation.46 In addition to active relaxation, the passive mechanical 
properties of the LV myocardium contribute to this presentation of diastolic dysfunction. 
On a structural/chamber level, this is made evident by elevations in chamber stiffness (KC) 
determined from end diastolic pressure-volume relations.3,47,48 On a local material level, 
the determination of regional myocardial stiffness (KM) from stress-strain or stress-
diameter relationships reveals increases in the passive stiffness of the cardiac myocyte and 
the extracellular matrix it is embedded within.42,49 Coupled together, abnormal relaxation 
and increases in stiffness ultimately initiate a cascade of events including elevations in LV 
filling pressures, dilation of the left atrium, and a presentation of the signs and symptoms 
of HFpEF.50,51 
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1.5 DISSERTATION SCOPE AND SPECIFIC AIMS 
The primary goal of this dissertation is to advance the state of knowledge in the 
field in regard to pathophysiological mechanisms which give rise to heart failure and how 
they interrelate with local changes in mechanical behavior and mechanical properties as a 
consequence of disease-induced remodeling. The central hypothesis of this study is that we 
can leverage echocardiographic imaging techniques to non-invasively quantify changes in 
biomechanical function and mechanical properties in a serial manner throughout the 
progression towards heart failure. The corollary to this hypothesis is that the observed 
changes in function and mechanical properties can, at least in part, be attributed to a 
reorganization of collagen within the extracellular matrix. This hypothesis was tested with 
a combinatorial approach of clinically-relevant large animal models of heart failure, novel 
image-processing techniques, and computational modeling. These results provide novel 
information on LV remodeling outcomes in clinically-relevant disease states and lay the 
groundwork for the evaluation of emergent therapeutic strategies that seek to curtail 
adverse remodeling. 
1.5.1 Aim 1 – Quantify regional and temporal changes in left ventricular strain and 
stiffness in a porcine model of myocardial infarction 
For the first time, STE was used to serially track regional biomechanical behavior 
and mechanical properties post-MI. We found that changes initially confined to the MI 
region extended throughout the myocardium in a non-uniform fashion over 28 days post-
MI. We posit that STE-based evaluation of regional changes in LV biomechanics could 
advance both clinical assessment of left ventricular remodeling and therapeutic strategies 
that target aberrant biomechanical behavior post-MI. 
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1.5.2 Aim 2 – Quantify changes in myocardial microstructure and mechanics secondary 
to left ventricular pressure overload 
Left ventricular pressure overload has been shown to give rise to the HFpEF 
phenotype. LVPO was induced in mature pigs by inflation of an implanted ascending aortic 
cuff for up to five weeks. Serial echocardiographic analyses of diastolic function and 
mechanical properties along with terminal histological analysis allowed for a correlative 
analysis of the abnormalities in the microstructural composition of the extracellular matrix 
and these observed changes in structure and function. Our findings support the use of serial 
biomechanical analysis to track the progression of HFpEF and present a translational 
method to stratify patient-specific risk and assess the efficacy of pharmacological and 
therapeutic approaches. 
1.5.3 Aim 3 – Develop a clinically-accessible tool for the identification of the passive 
mechanical properties of the left ventricular myocardium 
Sensitive techniques to track the rate and extent of remodeling are necessary to 
evaluate risk and treatment options on a patient-specific basis throughout the progression 
to heart failure. The technology we have developed is a novel and non-obvious extension 
of two-dimensional STE which allows for the definition of a constitutive relation for the 
regional left ventricular myocardium that links the states of stress and strain. This was 
accomplished through the use of an inverse finite element analysis approach along with a 
novel objective function which accounts for regional differences in strain and thickness. 
This technology allows for a comprehensive biomechanical analysis of the left ventricle to 
be performed in a clinical setting for the assessment of the rate and extent of myocardial 
remodeling in response to heart disease. 
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1.6 TABLES 
 
  
Table 1.1: Features that differentiate HFrEF from HFpEF. 
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1.7 FIGURES 
 
 
 
 
 
  
Figure 1.1: Anatomy of the heart and major blood vessels. 
There are four main chambers to the heart: right atrium, right ventricle, left atrium, and 
left ventricle. The atria and ventricles are separated by atrioventricular valves and the 
semilunar valves prevent backflow of blood from the major arteries to the ventricles. 
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Figure 1.2: Cardiovascular circulation. 
Blood collected in the right atrium is pumped into the right ventricle. Contraction of the 
right ventricle sends the blood through the pulmonary system for oxygenation. After 
oxygenation, the blood returns to the heart through the left atrium. Blood then goes to 
the left ventricle where the force is generated to pump the blood through the rest of the 
body. 
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Figure 1.3: Wigger’s Diagram. 
This diagram is a representation of the electrical and mechanical events of the cardiac 
cycle. By DanielChangMD, revised original work of DestinyQx, redrawn as SVG by 
xavax (Wikimedia Commons, File: Wiggers_Diagram.svg), “Wigger’s Diagram”, 
https://creativecommons.org/licenses/by-sa/2.5/legalcode 
 1 Torres W. M., Jacobs J., Doviak, H., Barlow S. C., Zile M. R., Shazly T., Spinale F. G.  
2018. Regional and temporal changes in left ventricular strain and stiffness in a porcine 
model of myocardial infarction. American Journal of Physiology – Heart and Circulatory 
Physiology. 315(4): H958-H967. Reprinted here with permission of publisher. 
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CHAPTER 2 
REGIONAL AND TEMPORAL CHANGES IN LEFT VENTRICULAR 
STRAIN AND STIFFNESS IN A PORCINE MODEL OF  
MYOCARDIAL INFARCTION  1 
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2.1 ABSTRACT 
The aim of this study was to serially track how myocardial infarction (MI) impacts 
regional myocardial strain and mechanical properties of the left ventricle (LV) in a large 
animal model. Post-MI remodeling has distinct regional effects throughout the LV 
myocardium. Regional quantification of LV biomechanical behavior could help explain 
changes in global function and thus advance clinical assessment of post-MI remodeling. 
The present study is based on a porcine MI model to characterize LV biomechanics over 
28 days post-MI via speckle-tracking echocardiography (STE). Regional myocardial strain 
and strain rate were recorded in the circumferential, radial, and longitudinal directions at 
baseline and at three, 14, and 28 days post-MI. Regional myocardial wall stress was 
calculated using standard echocardiographic metrics of geometry and Doppler-derived 
hemodynamic measurements. Regional diastolic myocardial stiffness was calculated from 
the resultant stress-strain relations. Peak strain and phasic strain rates were nonuniformly 
reduced throughout the myocardium post-MI, while time to peak strain was increased to a 
similar degree in the MI region and border zone by 28 days post-MI. Elevations in diastolic 
myocardial stiffness in the MI region plateaued at 14 days post-MI, after which a 
significant reduction in MI regional stiffness in the longitudinal direction occurred between 
14 and 28 days post-MI. Post-MI biomechanical changes in the LV myocardium were 
initially limited to the MI region but nonuniformly extended into the neighboring border 
zone and remote myocardium over 28 days post-MI. STE enabled quantification of 
regional and temporal differences in myocardial strain and diastolic stiffness, underscoring 
the potential of this technique for clinical assessment of post-MI remodeling. 
 
  
23 
 
2.2 INTRODUCTION 
 The post-MI period is accompanied by temporal changes in inflammatory-
signaling-proteolytic cascades within the MI region, which in turn give rise to changes in 
LV geometry, composition, and function in a process termed post-MI remodeling 52,53. 
Global changes in LV geometry (e.g., increased EDV) and pump function (e.g., reduced 
EF) are commonly used to assess the relative extent of post-MI remodeling 54–56. However, 
this is a spatially nonuniform process, as myocardial thinning (within the MI region) occurs 
concomitantly with hypertrophy (within the viable remote region) 35,36. As such, improved 
regional assessment of temporal changes throughout the myocardium may enhance clinical 
evaluation of the rate and extent of the post-MI remodeling process.  
In vivo regional mechanical behavior has been assessed post-MI in both basic 
scientific and clinical studies using techniques such as sonomicrometry, cardiac magnetic 
resonance imaging, and tissue Doppler-derived imaging 57–63. While these and other 
approaches have yielded critical information on the post-MI remodeling process, they have 
not been uniformly applied to assess LV regional function across the entire chamber and 
in a serial fashion due to several factors. In  large animal studies using sonomicrometry, 
high spatial and temporal resolution is offset by a limited field of view 58,59. In clinical 
studies, noninvasive approaches such as cardiac magnetic resonance imaging can provide 
high fidelity regional assessment of LV function, but lengthy acquisition and post-
processing times make it impractical to collect repeated measurements 60. Tissue Doppler-
derived imaging has also been applied in both large animal models and clinical settings to 
quantify regional myocardial strain with reported limitations stemming from a significant 
dependency on the angle of the ultrasound beam and low signal-to-noise ratio 61–63.  
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STE, an ultrasound-based technique which tracks the movement of intrinsic 
acoustic markers of the LV, has the potential to address limitations of tissue Doppler 
approaches. Past large animal and clinical studies have demonstrated the feasibility of STE 
in terms of post-MI assessment of LV regional function 64–72. It has been established that 
longitudinal strain patterns can be used to identify regions of ischemic injury and predict 
remodeling outcomes 64,65. Measures of global radial and circumferential strains have 
shown correlation with MI size and can enable differentiation between subendocardial and 
transmural infarction 67–69. STE can also capture the heterogeneous and temporal changes 
in LV strain in the minutes immediately after MI and over more extensive time intervals 
post-MI 70–72. Despite these advancements, there is a paucity of studies that have applied 
STE to serially assess the extent and magnitude of changes in regional strain over the 
critical early remodeling period (up to 28 days post-MI) in a large animal model. 
Furthermore, no studies to date have extended STE to track regional mechanical property 
changes post-MI. The current study utilizes a porcine model of an acute coronary syndrome 
and subsequent MI based on an intracoronary IR approach; STE is then performed up to 
28 days post-MI. We postulate that this combinatorial approach to the in-vivo 
quantification of LV mechanical behavior post-MI will yield novel insight into the 
progression of the post-MI remodeling process and thereby motivate the development of 
therapeutic strategies, which aim to mitigate these adverse effects. 
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2.3 METHODS 
2.3.1 IR Protocol 
Mature pigs (n=8) (Yorkshire, male, 22.0 ± 0.9 kg) were administered amiodarone 
(200 mg PO) and aspirin (81 mg PO) for three days pre-operatively and a broad-spectrum 
antibiotic (Draxxin, 2.5 mg/kg, IM) at least once pre-operatively. On the day of surgery, 
the pigs were sedated (ketamine/acepromazine/atropine: 22/1.1/0.04 mg/kg IM, 
respectively), intubated, and then maintained on 1.5 – 2.0 % isoflurane delivered in an 
oxygen/nitrous mixture (3:1 L/min, respectively). Buprenorphine (0.05 mg/kg IM) was 
administered as pre-surgery analgesia.  An intravenous infusion (via ear vein cannula) of 
Benadryl (25 mg) in conjunction with a continuous lidocaine infusion (4 mg/kg/hr) and 
lactated ringer’s solution (10 mL/kg/hr) was initiated. The region encompassing the right 
femoral artery was prepared in a sterile fashion, the main branch of the femoral artery 
surgically exposed, and a catheter introducer (6F Input Introducer Sheath, Medtronic) 
positioned and stabilized in the artery. A bolus of heparin was administered (4000 units, 
IV) prior to placement of the guide catheter followed by an additional bolus every hour 
(1000 units, IV). Under fluoroscopic guidance (GE OEC 9600, UT), a coronary 
angiography catheter/launcher (5F Launcher guiding catheter .058" HSI, Medtronic) was 
placed in the left coronary ostia, and an angioplasty balloon catheter containing an injection 
lumen (3mm x 10mm Sprinter OTW balloon catheter, Medtronic) was positioned in the 
lower portion of the left anterior descending artery (LAD; defined as 1 cm below the First 
Diagonal). The LAD was occluded by balloon inflation (12 ATM balloon inflation 
pressure, Everest 30 Disposable inflation device, Medtronic) and maintained for 90 
minutes. The balloon was then deflated, and the catheter system disengaged and removed. 
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The femoral artery was ligated, and the incision closed. A transdermal fentanyl patch was 
placed for three days for post-operative analgesia. Prior studies have demonstrated that this 
technique produces a highly-reproducible anteroapical ischemic region resulting in an MI, 
which constitutes approximately 8.7% ± 1.3% of the entire LV at 28 days post-MI 73,74. 
 All experimental protocols were approved by the Institutional Animal Care 
and Use Committees at the University of South Carolina and performed according to the 
National Institutes of Health guidelines for Care and Use of Laboratory Animals. 
2.3.2 Standard Echocardiography 
The day before the animals underwent the IR protocol, they were sedated 
(diazepam, 200 mg PO, Barr Laboratories, Pomona, NY), placed in a custom-designed 
sling, and echocardiography was performed (GE Vivid E9 with XDclear Ultrasound 
System: M5S (1.5-4.6 MHz) transducer probe). Cardiac dimensions and function were 
assessed by two-dimensional echocardiographic studies. The transthoracic images were 
acquired from a right parasternal approach and the LV was imaged in long axis and short 
axis views. The short axis views were taken at the level of the papillary muscles. EDV, 
ESV, and EF were calculated using the biplane method of disks. Pulse-wave Doppler, using 
a sample volume placed at the tips of the mitral valve leaflets, was used to determine the 
peak early mitral inflow velocity (E). Tissue Doppler assessment was used to calculate the 
peak early mitral annular velocity (E’) with a sample volume positioned at the lateral site 
of the mitral annulus. PCWP was calculated using the method proposed by Nagueh et al in 
1997. Additionally, wall thickness was collected at early- and end-diastole for each of the 
six conventional echocardiogram LV segments in the parasternal long-axis and papillary 
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level short-axis. The pigs were returned to the laboratory under identical sedation/study 
conditions at three, 14, and 28 days post-MI. 
2.3.3 Strain Imaging 
Digital loops of the two-dimensional echocardiography for the long axis and 
papillary short axis (acquired at 40 Hz) were stored on a hard disk and transferred to a 
workstation (EchoPac, Vingmed, General Electric) for post-processing. For each digital 
loop, a ROI was defined at the onset of the R-wave by manually identifying the endocardial 
and epicardial borders. The ROI was then discretized with a spatial mesh of acoustic 
clusters to be tracked on a frame-to-frame basis throughout a single cardiac cycle 7. The 
end of systole was defined as the point at which the LV cross-sectional area was at a 
minimum. After the semi-automated grouping of acoustic clusters in accordance with six 
anatomical locations (Figure 2.1A), regional tracking quality was assessed, and the ROI 
was manually adjusted by the operator to improve tracking quality where necessary. 
Successful tracking of the ROI allows for the definition of segmental lengths, which are 
computed at end diastole (L0) and continuously throughout the cardiac cycle (L). Local 
segmental strains (ε) and strain rates (γ) are then computed as: 
𝜀 =
𝐿−𝐿0
𝐿0
=
∆𝐿
𝐿0
      (2.1) 
𝛾 =
(∆𝐿/∆𝑡)
𝐿0
       (2.2) 
where Δt is the relative time in the cardiac cycle. Peak strain, systolic strain rate, and 
diastolic strain rate were quantified in the three normal directions: circumferential 
(papillary short axis), radial (papillary short axis), and longitudinal (long axis). 
Circumferential and longitudinal segmental strains/strain rates were quantified at the 
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epicardial, mid-myocardial, and endocardial surfaces. Global strain values were calculated 
as the mean segmental strain observed in the 18 myocardial segments in the circumferential 
and longitudinal directions and six segments in the radial direction. Obtained segmental 
strain and strain rate data were assessed for intra-observer variance by calculating the intra-
class correlation coefficient for a single operator under the assumption that systematic 
differences are relevant. The intra-class correlation coefficient for all measures of strain 
and strain rate ranged from 0.94 to 0.99. 
2.3.4 Aggregate Regional Definitions 
In this study, each pig had a total occlusion of the LAD. To facilitate data analysis, 
we defined the following aggregate regions: the MI region is all anterior and anteroseptum 
walls; the border zone is the apical and mid posterior, basal septal, and basal lateral walls; 
the remote region is the basal posterior and inferior walls. While the size of the MI region, 
and thus the size and location of the border zone, change over time post-MI, the use of 
consistent regions at all study time points allows for the continuous monitoring of local 
biomechanical changes throughout the myocardium.  
2.3.5 Mean Wall Stresses 
We modified a thick-walled ellipsoidal model proposed by Janz 24 to compute mean 
wall stresses. The mean circumferential wall stress (𝜎𝐶) was computed as:  
𝜎𝐶 =
𝑃𝑟2
2𝑡(𝑟+
𝑡
2
)
  (2.3) 
where (r) is the inner radius, (t) is the wall thickness, and (P) is the LV pressure. For the 
purposes of this study, (P) was assumed to equal zero at the onset on diastole and the PCWP 
at end-diastole.  
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The mean longitudinal wall stress (𝜎𝐿)  was computed as:  
𝜎𝐿 =
𝑃𝑟2
2𝑡(𝑠𝑖𝑛𝜃)(𝑟+
𝑡(𝑠𝑖𝑛𝜃)
2
)
  (2.4) 
where (Φ) is the angle between the normal vector from the endocardium at the ROI and 
the axis of revolution in the truncated ellipsoid model. 
2.3.6 Regional Diastolic Myocardial Stiffness 
Obtained values for mean wall stresses and segmental strains at the onset of diastole 
and end-diastole enabled calculation of regional diastolic myocardial stiffness in both the 
circumferential and longitudinal directions. The slope of the line between these two points 
in the stress-strain plane, developed in either the circumferential or longitudinal direction 
and referenced to the defined anatomical locations, was used to compute the regional 
diastolic myocardial stiffness (KMR) as: 
𝜅𝑀𝑅 =
𝜎𝐸𝐷
|𝜀𝐷0|
      (2.5) 
where 𝜎𝐸𝐷 and 𝜀𝐷0 are the end diastolic mean wall stress and segmental strain at the onset 
of diastole, respectively. 
2.3.7 Statistical Analysis 
Data are reported as the mean ± standard error of the mean. A post hoc analysis of 
baseline (pre-MI) global stiffness values with an assumption of a 30% effect and sample 
size of eight yielded a statistical power of greater than 80%. The comparative analysis was 
performed with either a one-way or two-way analysis of variance followed by pair-wise 
comparisons using the LSD post hoc study. All statistical analyses were performed with 
SPSS software (version 24.0, SPSS Inc). A p-value less than 0.05 was considered 
statistically significant. 
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2.4 RESULTS 
2.4.1 LV Function and Geometry 
Assessments of LV function and geometry at baseline and at specific post-MI time 
points are shown in Table 2.1.  At 28 days post-MI, LV EF fell by over 40%, LV EDV 
more than doubled, and PCWP increased by 80% relative to baseline values.   
2.4.2 STE-Based Strain Measurements 
Representative plots of mid-myocardial segmental strains (Figure 2.1B) 
demonstrate that STE provided a continuous strain measurement over the cardiac cycle at 
all specified anatomical locations. As depicted by a representative LV circumferential 
section, the MI region, border zone, and remote region are contained within the designated 
myocardial regions at 28 days post-MI, thus supporting the aggregate definition of these 
regions throughout the study (Figure 2.2). Spatial maps of peak segmental strains 
qualitatively show that post-MI changes varied throughout the myocardium and exhibited 
obvious directional dependence (Figure 2.3). At three days post-MI, peak global strain in 
the radial and longitudinal directions decreased by approximately 40%, whereas reduction 
in the circumferential direction was not significant until 28 days post-MI.   
The relative time at which peak strain occurred in the MI region increased by 
approximately 30%-40% with respect to baseline at three days post-MI in all directions, 
with these early changes in the circumferential and longitudinal directions largely 
maintained throughout the study observation period (Figure 2.4). Within the border zone, 
an approximate 30% increase in the relative time to peak strain occurred at all post-MI 
times in the radial direction, but significant increases in the circumferential and 
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longitudinal directions were only recorded at 28 days post-MI. The remote region exhibited 
the least pronounced changes, as the only significant deviations from baseline were found 
in the radial direction at 28 days post-MI.   
2.4.3 Phasic Strain Rates 
Spatial maps of segmental strain rates show that MI impacted both phases of the 
cardiac cycle and that the greatest reductions in strain rates primarily occurred within the 
MI region (Figure 2.5). Reductions of over 50% in global systolic strain rate were observed 
at three days post-MI in the radial and longitudinal directions but were not significant until 
28 days post-MI in the circumferential direction. Global diastolic strain rates were 
relatively preserved post-MI with significant reductions observed only at 14- and 28-days 
post-MI in the longitudinal direction.  
2.4.4 Mean Wall Stresses and Diastolic Myocardial Stiffness 
End-diastolic mean wall stress monotonically increased throughout the 28-day 
observation period in both the circumferential and longitudinal directions with all regional 
values approximately doubling with respect to baseline by 28 days post-MI (Figure 2.6). 
Spatial maps of diastolic myocardial stiffness show that mechanical heterogeneity 
evidently increased post-MI (Figure 2.7A). Global diastolic myocardial stiffness 
underwent a greater than three-fold elevation by 14 days post-MI in the circumferential 
direction and three-fold elevation by three days post-MI in the longitudinal direction. In 
the longitudinal direction, significant diastolic myocardial stiffness elevations occurred in 
the MI region and border zone by three days post-MI and by 14 days post-MI in the remote 
region (Figure 2.7B). All three regions exhibited significantly elevated diastolic 
myocardial stiffness by 14 days post-MI in the circumferential direction. In the MI region, 
  
32 
 
diastolic myocardial stiffness in both directions was maximal at 14 days post-MI. In the 
longitudinal direction, an approximate 40% decrease in stiffness from this maximal value 
occurred between 14- and 28-days post-MI. 
 
2.5 DISCUSSION 
2.5.1 Study Overview 
Changes in LV geometry and function invariably occur following MI in a 
multifactorial process termed post-MI remodeling 52,53. Given the inherent spatial 
nonuniformity of post-MI remodeling, approaches for quantifying LV function in a global 
context can be problematic, and therefore assessment of regional biomechanics may 
provide improved insight into this process. The present study addressed this issue by 
serially examining LV strain and strain rates, indices of myocardial function, in defined 
myocardial regions post-MI. Using a large animal model of post-MI remodeling and STE-
derived indices, the significant findings from this study were two-fold. First, myocardial 
strain and strain rate fell within the MI region at three days post-MI, consistent with a loss 
of viable myocardium and hence contractile capacity. However, while the reduction in 
strain patterns was confined initially within the MI region, this reduction nonuniformly 
extended into the viable LV myocardial regions over one-month post-MI. Second, when 
regional myocardial diastolic stiffness was computed using local stress-strain relationships, 
a biphasic change within the MI region was observed. Specifically, diastolic myocardial 
stiffness initially increased within the MI region but at later post-MI time points remained 
constant in the circumferential direction and significantly fell in the longitudinal direction. 
Despite these regional and directional differences, diastolic myocardial stiffness was 
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significantly elevated throughout the entire myocardium by 28 days post-MI. Thus, serial 
assessment of regional LV function post-MI identified that time- and region-dependent 
changes in myocardial mechanical properties occur over 28 days post-MI, potentially 
providing more sensitive response variables when evaluating disease progression and 
therapeutic interventions. 
2.5.2 Previous Supportive Findings 
STE-based strain measures in our study were comparable to previous large animal 
and clinical studies. Specifically, our baseline global strain values fell within normal ranges 
defined by a meta-analysis of over 2,500 human subjects 75. Additionally, directional 
changes in peak strain observed in the MI region, border zone, and remote region track 
well with those reported in other large animal models 70,71. Our data also support previous 
studies that found elevated MI region stiffness 76–79, including via sonomicrometry 58 and 
three-dimensional magnetic resonance 80. Moreover, results from planar bi-axial 
mechanical testing on freshly excised square samples of remote and infarcted myocardium 
showed that MI region stiffness peaked at one- to two-weeks post-MI, followed by a period 
of decreasing stiffness 81.  
2.5.3 Mechanistic Implications  
The present study identified unique spatial, directional, and temporal variations in 
regional function during post-MI remodeling, which are associated with increased 
mechanical heterogeneity throughout the LV myocardium. We posit that this mechanical 
heterogeneity may be the biophysical stimulus that is translated into cellular and 
extracellular changes within the MI and surrounding region, ultimately contributing to MI 
expansion and eventually LV failure.  For example, during the first 14 days post-MI, the 
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diastolic myocardial stiffness of the MI region and the neighboring border zone became 
increasingly disparate, exemplified by the nearly order-of-magnitude greater MI region 
stiffness in the longitudinal direction. Such abrupt spatial gradients in mechanical stiffness 
that emerge between the MI and viable regions likely induce localized elevations in 
myocardial wall stress and dyskinesis throughout the cardiac cycle, which in turn would 
stimulate further remodeling and the progressive expansion of the MI region 82. The 
reduction in stiffness of the MI region observed at 28 days post-MI relative to 14 days post-
MI may facilitate the continued expansion of the MI region as evidenced by the increase 
in LV EDV over that period. Furthermore, relative values of border zone/MI region 
stiffness at 14- and 28-days post-MI suggest that at the terminal time point, mechanical 
properties throughout the myocardium become more homogenous in both the 
circumferential and longitudinal directions. Such property homogenization may, in turn, 
suggest an approach to mechanical homeostasis by 28 days post-MI – commensurate with 
the plateau in MI region expansion reported in previous studies 57. Conversely, the 
progressive stiffening of the hypertrophied remote region between 14 and 28 days may 
play a pivotal role in driving the elevations in PCWP which may, in turn, facilitate the LV 
dilation. To promote further association of regional mechanical property changes with 
global LV function, we consider as an index of LV chamber stiffness the ratio between 
PCWP and LV EDV. When computed using our data, this index at baseline is valued as 
0.24 ± 0.04 and is found to be consistently reduced by 40% relative to baseline at 14- and 
28-days post-MI. Antithetical changes in diastolic myocardial stiffness of the MI region 
and remote region between 14 and 28 days post-MI may explain the relatively constant 
index of LV chamber stiffness over this post-MI period. The coincidence between the 
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divergence of regional changes in myocardial mechanical properties and the development 
of congestive symptoms suggests that regional stiffness variations may be a key factor, and 
thus therapeutic target, in heart failure progression. 
These biomechanical changes are also seemingly synchronized with deterministic 
biological processes that occur in and around the MI region. These changes include 
fibroblast proliferation and collagen deposition – resulting in the formation of a mature 
scar composed of extracellular matrix by 14 days post-MI 83. This intermediate phase of 
post-MI remodeling also concurs with the highest disparity in fibrillar collagen content 
between the MI region and border zone and dynamic changes in protein expression 
profiles, which directly modulate the reparative response 84. Furthermore, there is evidence 
that many of these regional biophysical changes are modulated by mechanosensitive 
cardiac cells that sense and respond to their local mechanical environment 85. To that end, 
mechanical heterogeneity that emerges post-MI represents a biophysical response variable 
that can explain temporal and spatial variations in key biological processes that occur 
during post-MI remodeling.  
2.5.4 Therapeutic Implications 
While cause and effect relationships are difficult to discern with respect to 
synchronized biological versus biomechanical changes, our data support the regional 
modulation of myocardial mechanical properties as a potential therapeutic target. As 
suggested above, the increase in EDV from 14 to 28 days may be facilitated by a decrease 
in MI region stiffness, suggesting that treatment to maintain or increase MI region stiffness 
may blunt dilation. Similarly, the increase in PCWP from 14 to 28 days may be facilitated 
by an increase in remote region stiffness, suggesting that treatment to decrease remote 
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region stiffness may also blunt dilation. Indeed, previous studies show that biomaterials 
directly injected into the MI region acutely stiffen the myocardium and effectively curtail 
the adverse effects of post-MI remodeling 86,87. Regional biomechanical assessment can be 
used to advance local biomaterial injection strategies, including the optimization of 
biomaterial mechanical properties, total amount, and spatial distribution upon injection, 
such that mechanical heterogeneity is limited in the early stages of post-MI remodeling. 
This general concept is supported by previous results obtained with finite element 
simulations, which predict that biomaterial injections concentrated within the border zone 
(as opposed to uniformly delivered throughout the MI region) attenuate myocardial wall 
stress and promote efficient pump function 88.   
STE has been previously used to discriminate between infarcted and contractile 
myocardium post-MI 89.  Moreover, many studies have shown the utility of quantifying 
global values of STE-derived strain and strain rate with good feasibility, reproducibility, 
and accuracy in clinical and large animal populations 64–72. In accordance with these prior 
studies, we found significant reductions in global myocardial strain and strain rate post-
MI. While global strain has been extensively quantified in the post-MI context, regional 
measurements in our study suggest that the initially antithetical changes in the MI and 
remote regions likely weaken the sensitivity and diagnostic strength of traditional global 
metrics of function. Furthermore, this study demonstrates that STE-derived myocardial 
strain combined with traditional echocardiography and Doppler-derived hemodynamic 
parameters can be used to compute a regional diastolic myocardial stiffness. While an 
analogous technique has been applied to aortic aneurysms 90, we are the first to 
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noninvasively quantify regional diastolic stiffness using STE in the context of post-MI 
remodeling.  
2.5.5 Study Limitations 
Several study limitations must be considered for careful interpretation of the 
obtained results. Firstly, all metrics of LV function are dependent on load. To that end, the 
findings from this study only account for patient-specific variance in hemodynamics 
through the estimation of LV pressure at end-diastole (PCWP) and an assumption of 
negligible LV pressure at the onset of diastole. Additionally, as with all echocardiographic 
techniques, successful quantification of myocardial strain via STE is highly dependent on 
image quality. To translate this technology into a clinical setting, one must consider that 
the ability to capture echocardiographic images of sufficient quality is markedly impaired 
in obese patients or patients with respiratory disorders. However, we expect that the clinical 
utility of the regional tracking of segmental strains will markedly increase as the underlying 
technology becomes more reproducible and reliable.  Furthermore, these findings were for 
an anteroapical MI location in a porcine model and thus may not hold true with different 
MI locations, severity of myocardial ischemia, and/or across species. Finally, 
biomechanical changes were only assessed over 28 days post-MI in our study. Although 
this period has been shown to exhibit significant collagen deposition in a porcine model 91, 
care must be taken when extrapolating these findings into long-term effects given evidence 
that there are changes in LV strain and strain rate that continue through 1-3 months post-
MI 26.  
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2.5.6 Conclusion 
Post-MI remodeling induced progressive changes in LV biomechanics that 
manifest as regional differences in myocardial strain and strain rate over 28 days post-MI. 
For the first time, the utility of STE was extended in a large animal model to quantify 
regional diastolic myocardial stiffness in a serial fashion post-MI. Finally, this study 
identified the biphasic and at times opposing nature of regional changes in myocardial 
diastolic stiffness, which in turn is a likely contributing factor for a “feed forward” 
mechanism for adverse LV post-MI remodeling. Future therapeutic strategies that mitigate 
this significant regional stiffness gradient between the MI and adjacent viable myocardium 
may be a potential target for attenuating post-MI remodeling.     
 
2.6 ACKNOWLEDGEMENTS 
This work was supported by the National Institute of Health Grants 
5R01HL111090 and R01HL130792-01A1S1 (Supplement) as well as a Merit Award from 
the Veteran’s Affairs Health Administration (BX000168-06). 
 
  
 
39 
 
2.7 TABLES 
 
Table 2.1: Speckle tracking echocardiography enables quantification of 
myocardial segmental strain. 
 
  Baseline 3 Days 14 Days 28 Days 
     
 EF [%] 69.1 ± 0.8 49.4 ± 2.7* 37.8 ± 2.3*† 37.5 ± 3.4*† 
 LV EDV [mL] 37.2 ± 1.5 59.3 ± 5.1* 77.2 ± 6.5*† 83.6 ± 6.4*† 
 PCWP [mmHg] 7.6 ± 0.6 9.3 ± 0.6* 12.2 ± 0.9*† 13.9 ± 1.1*† 
      
 
* p<0.05 vs. Respective Baseline Value, † p<0.05 vs. Respective 3 days Value, EF: ejection fraction, LV EDV: left ventricular end 
diastolic volume, PCWP: pulmonary capillary wedge pressure (n=8, one-way analysis of variance with post hoc LSD comparisons). 
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2.8 FIGURES 
Figure 2.1: Speckle tracking echocardiography enables quantification of 
myocardial segmental strain. 
(A) Representative echocardiographic images obtained 28 days post-MI (at end 
diastole) divided into six anatomical zones for speckle tracking. (B) Representative 
segmental strain curves of the LV mid-wall over one cardiac cycle at 28 days post-MI 
in the circumferential, radial, and longitudinal directions. 
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Figure 2.2: Definition of aggregate regions based on MI location  
(A) Representative LV circumferential section cut across the central portion of the MI 
and stained with triphenyltetrazolium chloride shows the (B) agreement between 
designated aggregate MI region, border zone, and remote region at 28 days post-MI. 
The jagged line represents the edges of the MI region 
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Figure 2.3: Peak myocardial strain  
Spatial maps of the absolute value of peak myocardial segmental strain in the 
circumferential (top row), radial (middle row), and longitudinal (bottom row) directions 
at baseline and at three, 14, and 28 days post-MI. Inscribed values indicate the peak 
global strain reported as the mean absolute value ± standard error of the mean. * p<0.05 
vs. respective baseline value (n=8, one-way analysis of variance with post hoc LSD 
comparisons). 
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Figure 2.4: Relative time to peak myocardial strain  
The relative time at which peak myocardial strain occurred for each region at baseline 
and at three, 14, and 28 days post-MI, with relative time defined as percent completion 
of one cardiac cycle; * p<0.05 vs. respective baseline value, † p<0.05 vs. respective 
three days value (n=8, one-way analysis of variance with post hoc LSD comparisons). 
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Figure 2.5: Phasic myocardial strain rate  
Spatial maps of the absolute value of the (A) systolic and (B) diastolic myocardial 
segmental strain rates in the circumferential (top rows), radial (middle rows), and 
longitudinal (bottom rows) directions at baseline and at three, 14, and 28 days post-MI. 
Inscribed values indicate the global strain rate reported as the mean absolute value ± 
standard error of the mean. * p<0.05 vs. respective baseline value (n=8, one-way 
analysis of variance with post hoc LSD comparisons). 
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Figure 2.6: Stress-strain relations  
Regional (MI region, border zone, and remote region) myocardial stress-strain relations 
were computed at early- and end-diastole in the circumferential and longitudinal 
directions at baseline and at three, 14, and 28 days post-MI. * p<0.05 vs. respective 
baseline stress or strain value (n=8, one-way analysis of variance with post hoc LSD 
comparisons). 
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Figure 2.7: Diastolic myocardial stiffness  
(A) Spatial maps of diastolic myocardial stiffness in the circumferential and 
longitudinal directions at baseline and at three, 14, and 28 days post-MI. Inscribed 
values indicate the myocardial stiffness reported as the mean value ± standard error of 
the mean. (B) Region-specific change in myocardial stiffness post-MI. * p<0.05 vs. 
respective baseline value, † p<0.05 vs. respective remote region value, ‡ p<0.05 vs. 
respective border zone value, § p<0.05 vs. respective 14-day post-MI value (n=8, two-
way analysis of variance with post hoc LSD comparisons). 
 2 Torres W. M., Jacobs J., Doviak, H., Moore A., Freeburg L., Hoenes, A., Barlow S. C., 
Zile M. R., Shazly T., Spinale F. G.  Changes in myocardial microstructure and 
mechanics with progressive left ventricular overload. To be submitted to Circulation. 
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CHAPTER 3 
CHANGES IN MYOCARDIAL MICROSTRUCTURE AND 
MECHANICS WITH PROGRESSIVE LEFT VENTRICULAR 
PRESSURE OVERLOAD  2 
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3.1 ABSTRACT 
Heart failure with preserved ejection fraction (HFpEF) secondary to left ventricular 
pressure overload (LVPO) is a leading cause of morbidity and mortality. Treatment options 
for HFpEF are limited by our poor understanding of disease phenotype and factors that 
underlie its progression. Our study seeks to assess the dynamic interplay between regional 
changes in myocardial geometry, microstructure, mechanical behavior, and mechanical 
properties that occur in response to progressive LVPO in a large animal model. LVPO was 
induced in mature pigs by progressive inflation of an implanted ascending aortic cuff for 
up to five weeks. Serial echocardiography was used to quantify left ventricle (LV) chamber 
stiffness and left atrial (LA) area, as well as regional myocardial strain and stiffness. Light 
microscopy and second harmonic imaging (SHG) were used to evaluate myocardial 
collagen content and microstructure. LVPO induced minimal perturbations in ejection 
fraction and peak systolic strains, but significant elevations in LV chamber stiffness, LA 
area, and regional myocardial stiffness. Analyses of myocardial collagen content and 
microstructure suggested that increased myocardial stiffness is promoted by not only an 
increase in collagen mass, but also a realignment of the collagen fibers and a reduction of 
their undulation. Myocardial microstructural and mechanical data were integrated to 
develop a novel index of local biomechanical adaptation to LVPO. Regression modeling 
suggest that this index, when obtained shortly after the onset of LVPO, is predictive of 
progressive increases in LV chamber stiffness. Our findings support the use of serial 
biomechanical analysis b to track the progression of HFpEF and present a translational 
method to stratify patient risk and assess the efficacy of pharmacological and therapeutic 
approaches.  
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3.2 INTRODUCTION 
The rate and incidence of heart failure (HF) continues to escalate and recent 
statistics have identified this disease as the leading cause of morbidity and mortality – 
eclipsing all other chronic diseases.30 While significant progress has been achieved in 
therapeutic retardation or elimination of other major illnesses such as cancer, these 
advancements have not been as forthcoming for HF. One contributory factor for this is that, 
unlike cancer which is classified by morphology, cell type, and molecular/genetic profiles, 
HF has been historically considered as a single entity fundamentally defined by 
symptomatology. However, it is also recognized that HF arises from distinctly different 
etiologies, which, in turn, have demonstrated distinctly different therapeutic responses and 
clinical outcomes.31,32  
While the precise categorization of HF is continuously evolving, a generalized 
dichotomy can be made between patients presenting with or without significant left 
ventricular (LV) pump dysfunction. Specifically, if LV ejection fraction (EF) is below 
45%, this is defined as HF with reduced EF (HFrEF), whereas if HF symptoms are present 
and EF is above this value, then it is defined as HF with a preserved EF (HFpEF). Using 
this HF classification scheme, it has been estimated that patients with these HF phenotypes 
are equally distributed.31 Randomized clinical trials using combinatorial pharmacology or 
device-driven therapies have demonstrated significant improvement in HF progression and 
clinical outcomes in patients with HFrEF, but not in patients with HFpEF.92–99 In addition, 
while the functional progression of HFrEF can be monitored by serial assessment of 
changes in EF, the natural history of HFpEF is not as easily tracked or well understood.51,100 
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As a result, advancements in the prognosis and strategic interventions for HFpEF have 
been met with challenges.  
One rate limiting step in the research progress for HFpEF is a paucity of 
translationally relevant animal models that recapitulate key features of this HF 
phenotype.101,102 Specifically, HFpEF can arise from progressive and prolonged LV 
pressure overload (LVPO) rather than from an acute pathological stimulus such as 
myocardial ischemia, which progresses to HFrEF.103–106 In addition, a key component in 
the progression of HFpEF is the development of LV diastolic dysfunction, which requires 
sensitive measures of LV diastole and can be difficult to assess in a serial manner.107,108 
We have previously established a porcine model of progressive LVPO, which resulted in 
significant LV hypertrophy with stable EF, but with evidence for impaired diastolic 
function, consistent with the clinical phenotype of HFpEF.109  
The overall goal of this study was to utilize this relevant pre-clinical model to parse 
out the relationship between the LV geometry, collagen microstructure, mechanical 
behavior, and mechanical properties in development of HFpEF. The central hypothesis of 
this study was that LV remodeling in response to LVPO is characterized by an increase in 
collagen mass and a change in the collagen microstructure. We posit that these changes 
will be the driving factor behind progressive changes in both LV chamber stiffness and 
myocardial mechanical properties. To that end, in the present study we employ a 
combinatorial approach of non-invasive imaging techniques along with an advanced 
optical analysis of the collagen microstructure to improve upon the current understanding 
of the mechanisms which give rise to the progression of HFpEF. 
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3.3 METHODS 
The present study induced progressive LVPO in pigs for up to a 5 week period, 
over which regional myocardial strain and stiffness were quantified using speckle tracking 
echocardiography and, at the terminal time point, myocardial collagen content and 
microstructure using quantitative histomorphometry and second harmonic generation 
imaging.7,57,61,110–113 These functional and serial results were then examined with a focus 
upon identifying factors that would contribute to and potentially predict changes in LV 
chamber stiffness, a hallmark of HFpEF progression.47,50,109,114–119 
3.3.1 Aortic Cuff Placement 
Yorkshire pigs (n=15, 15.8±0.6 kg, Hambone Farms, Orangeburg, SC) were 
anesthetized with isoflurane (3%/1.5L/min) and nitrous oxide (0.5L/min). Through a left 
thoracotomy, the pericardium was incised and a 12 mm inflatable silastic vascular cuff 
(Access Technologies, Skokie, IL) was secured around the supracoronary ascending aorta 
without inducing aortic constriction. A uniform length of silastic tubing was connected to 
a subcutaneous access port (Access Technologies, Skokie, IL) for subsequent serial 
hydraulic mediated expansion of the aortic cuff. The animals were allowed to recover for 
one week. Twelve age-matched referent control pigs were also used for comparative 
analyses. A prospective power analysis assuming a doubling of key response variables 
relative to the subject-matched baseline value and a standard error of measurement of 40% 
yielded a minimum study power of 0.80 for all experimental groups. All animals were 
treated and cared for in accordance with the National Institutes of Health Guide for the 
Care and Use of Laboratory Animals (Eighth Edition. Washington, DC: 2011) and all 
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experimental protocols were approved by Institutional Animal Care and Use Committees 
at the University of South Carolina. 
3.3.2 Progressive Induction of LVPO 
Following the one-week recovery period, the cuff was inflated through the access 
port (via 0.45 mL glycerol) to achieve a specific target gradient of 75 mmHg across the 
cuff and induce LVPO. At weekly intervals thereafter, the cuff was further inflated 
(0.25 mL increments) to cause a stepwise increase in the pressure gradient (25 mmHg 
increase/inflation). At either four (n=7) or five weeks (n=7) post-PO, the animals were 
again anesthetized (5% isoflurane) and the LV was harvested. 
3.3.3 Standard Echocardiography 
Standard echocardiography was performed weekly throughout the study (GE Vivid 
E9 with XDclear Ultrasound System: M5S (1.5-4.6 MHz) transducer probe). Left 
ventricular and left atrial dimensions and function were assessed by two-dimensional and 
M-mode echocardiographic studies. The transthoracic images were acquired from a right 
parasternal approach as well as an abdominal/sub xyphoid approach. The LV was imaged 
in the short- and long-axes. The short-axis views were taken at the level of the papillary 
muscles. End-diastolic volume (EDV), end-systolic volume (ESV), and EF were calculated 
using the biplane method of disks. Left atrial (LA) area was determined from the 
anteroposterior dimensions acquired from the parasternal long-axis view. Additionally, 
wall thickness and LV internal dimension were collected at early- and end-diastole for each 
of the six conventional echocardiogram segments of the LV in the parasternal long-axis 
and papillary level short-axis. Finally, following the convention established by Devereux 
and colleagues, LV mass was estimated from M-mode measurements.4 Echocardiographic 
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studies under identical sedation/acquisition conditions were performed at weekly intervals 
until the terminal timepoint. 
3.3.4 Definition of Normal Range for Left Ventricular mass 
LV mass measurements (computed as described above) were collected from a 
cohort of 100 male Yorkshire pigs (body weights ranging from 13.4 kg to 33.1 kg) that 
were part of this laboratory’s prior studies completed between 2012-2017. A normogram 
for LV mass as a function of body weight was generated by fitting a linear regression 
through the resultant data set with a 95% confidence interval. This normogram provides a 
basis to assess pressure-induced elevations in LV mass with due account of normal growth. 
3.3.5 Terminal Evaluation of Global and Regional Left Ventricular Function 
In a subset of referent control (n=5) and banded (n=5) pigs, LV pressure and 
dimensions were obtained. Briefly, the pigs were anesthetized with fentanyl (50 µg) and 
propofol (100 mg), and a cardiac catheter introducer with a side-arm (9F, Medtronic, 
Minneapolis, MN) connected to a pressure transducer was placed in the right carotid artery 
and advanced to the ascending aorta. After which, a multi-lumened thermodilution catheter 
(7.5F, Baxter Healthcare Corp., Irvine, CA) was advanced through the right external 
jugular vein and positioned in the pulmonary artery. Pulmonary capillary wedge pressure, 
a surrogate for end-diastolic pressure (PED), was measured using conventional methods.
120 
Afterwards, a microtipped transducer (7.5F, Millar Instruments Inc., Houston, TX) was 
placed in the LV through a small apical stab wound. Pressure data was recorded at a 
sampling frequency of 100 Hz and digitized (Ponemah, Harvard Bioscience Inc., Holliston, 
MA). Following the placement of the instrumentation, an ultrasound transducer (GE Vivid 
E9 with XDclear Ultrasound System: M5S (1.5-4.6 MHz) transducer probe) was positioned 
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for transthoracic imaging of the LV short-axis and measurement of continuous LV volume 
and wall thickness.121 Steady-state LV function was determined with simultaneous 
acquisition of pressure and echocardiographic data with the ventilator temporarily 
suspended in order to prevent respiratory artifact. Following steady-state measurements, 
LV preload was altered with sequential occlusion and release of the inferior vena cava with 
vascular ligature. Again, simultaneous pressure and echocardiographic data were collected 
during occlusion and release. 
After data acquisition was complete, the digitized pressure and LV dimension data 
were aligned using the R-wave of the simultaneously recorded ECG from each modality. 
The aligned pressure and dimension data for the steady-state and caval occlusion cardiac 
cycles were used to determine the regional myocardial stiffness constant and LV chamber 
stiffness, respectively, using the methods derived by Mirsky and Pasipoularides.21,22 
3.3.6 Non-Invasive Estimation of End-Diastolic Pressure and Chamber Stiffness 
While direct measurements of LV pressure and chamber stiffness via cardiac 
catheterization have been accepted as the gold standard, non-invasive estimates of these 
response variables were necessary in order to track the progression of disease and LV 
remodeling. Accordingly, obtained measurements of pulmonary capillary wedge pressure 
and temporally-matched LA area measurements in a subset of referent control (n=5) and 
banded (n=8) animals were used to identify an expression for non-invasive estimation of 
end-diastolic pressure, specifically 𝑃𝐸𝐷 = 1.88𝑒
0.16(𝐿𝐴 𝑎𝑟𝑒𝑎) (R2=0.91). After applying this 
regression-based non-invasive estimation of 𝑃𝐸𝐷 to the entire study cohort, a non-invasive 
surrogate of LV chamber stiffness (𝐾𝐶
∗) was computed as the ratio between 𝑃𝐸𝐷 and 
EDV.122 
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3.3.7 Speckle Tracking Echocardiography 
Three consecutive digital loops of the two-dimensional echocardiography for the 
long-axis and short-axis were stored on a hard disk and transferred to a workstation 
(EchoPac, Vingmed, General Electric) for post-processing. For each echocardiographic 
digital loop, a region of interest (ROI) was defined at the onset of the R-wave by manually 
tracing the endocardial and epicardial borders. The ROI was then discretized with a spatial 
mesh of acoustic clusters to be tracked on a frame-to-frame basis throughout the cardiac 
cycle (R-R interval).7 The end of systole was defined as the point at which the LV cross-
sectional area was at a minimum. After the semi-automated grouping of acoustic clusters 
in accordance with six predetermined anatomical locations, regional tracking quality was 
assessed, and the ROI was manually adjusted by the operator to improve tracking quality 
where necessary. Successful tracking of the ROI allows for the definition of segmental 
lengths, which are computed at end diastole (L0) and continuously throughout the cardiac 
cycle (L). Local segmental strains (ε) and strain rates (γ) are then computed as: 
𝜀 =
𝐿−𝐿0
𝐿0
=
∆𝐿
𝐿0
     (3.1) 
𝛾 =
(∆𝐿/∆𝑡)
𝐿0
     (3.2) 
where Δt is the relative time in the cardiac cycle. Peak strain and diastolic strain rate were 
quantified in the two normal directions, circumferential (short-axis) and longitudinal (long-
axis), at the endocardial, mid-wall, and epicardial surfaces. Global strain values were 
calculated from the total length of all six segments. Obtained segmental strain and strain 
rate data were assessed for intra-observer variance by calculating the intra-class correlation 
coefficient for a single operator under the assumption that systematic differences are 
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relevant. The intra-class correlation coefficient for all measures of strain and strain rate 
ranged from 0.94 to 0.99. 
3.3.8 Mean Wall Stresses 
We modified a thick-walled ellipsoidal model proposed by Janz to compute mean 
wall stresses.24 The mean circumferential wall stress (𝜎𝐶) was computed as:  
𝜎𝐶 =
𝑃𝑟2
2𝑡(𝑟+
𝑡
2
)
 (3.3) 
where (r) is the inner radius, (t) is the wall thickness, and (P) is the LV pressure. For the 
purposes of this study, (P) was assumed to equal zero at the onset on diastole and the PCWP 
at end-diastole.  
The mean longitudinal wall stress (𝜎𝐿)  was computed as:  
𝜎𝐿 =
𝑃𝑟2
2𝑡(𝑠𝑖𝑛𝜃)(𝑟+
𝑡(𝑠𝑖𝑛𝜃)
2
)
  (3.4) 
where (Φ) is the angle between the normal vector from the endocardium at the ROI and 
the axis of revolution in the truncated ellipsoid model. 
3.3.9 Regional Diastolic Myocardial Stiffness 
Obtained values for mean wall stresses and segmental strains at the onset of diastole 
and end-diastole enabled calculation of regional diastolic myocardial stiffness in both the 
circumferential and longitudinal directions. The slope of the line between these two points 
in the stress-strain plane, developed in either the circumferential or longitudinal direction 
and referenced to the defined anatomical locations, was used to compute the regional 
diastolic myocardial stiffness (KMR) as: 
𝜅𝑀𝑅 =
𝜎𝐸𝐷
|𝜀𝐷0|
     (3.5) 
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where 𝜎𝐸𝐷 and 𝜀𝐷0 are the end diastolic mean wall stress and segmental strain at the onset 
of diastole, respectively. 
3.3.10 Second-Harmonic Generation Imaging 
Upon terminal heart harvest, a 1-inch thick bisection of the left ventricle was fixed 
in 10% formalin – preserving the native orientation and configuration of the collagen fibers 
– and refrigerated for histological evaluation. The LV lateral free-wall myocardium was 
later sectioned into thin, 200 µm sections using a vibratome and placed on the motorized 
stage of a multiphoton microscope (Leica TCS SP8 MP, Leica Microsystems). Short-
pulsed infrared lasers were used to create non-linear polarization effects in the form of 
second-harmonic generation (SHG) signals at a magnification of 25x. Images were 
acquired for a fixed sample area of 0.2 mm2 at depth intervals of 1.5 µm. 
3.3.11 Automated Tracing of Individual Collagen Fibers 
Two-dimensional images acquired from the multiphoton microscope were 
converted to 8-bit greyscale and virtually stacked in three-dimensions using the Amira 
software package.123 For the fully-automated tracing of individual collagen fibers, we 
modified the previously described techniques developed for electron tomography,124,125 
which have been packaged into the XTracing filament detection extension available for 
Amira. In brief, this tracing algorithm consists of two main steps: template matching and a 
line search approach. A correlation field is generated by computing the cross-correlation 
of the voxels in the three-dimensional stack with a cylindrical template. This cylindrical 
template mimics a short collagen fiber segment with a mask radius of 5 µm and a length of 
20 µm. The correlation was computed for each voxel on a NVIDIA Quadro M2000 
graphics processing unit. The line search approach was then used to iteratively identify the 
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voxels on the centerline of each collagen fiber. From an initial seed point, a search cone 
spanning 20 µm and 45 degrees was used to identify candidate points that were scored on 
the basis of continuity, curvature, and deviations from the orientation field. The line search 
stops when the search cone fails to identify candidate points with scores above the 
minimum threshold. 
3.3.12 Characterization of the Collagen Structure 
Each collagen fiber was evaluated with respect to orientation and undulation. Two 
angles were used to define the fiber orientation. The azimuthal angle (φ) refers to angle 
from the positive radial axis of the fiber’s projection on the longitudinal-radial plane, where 
φ=0º is then the radial direction. The elevation angle (ϑ) refers to the angle from the positive 
circumferential axis of the fiber’s projection on the circumferential-longitudinal plane, 
where ϑ=0º and ϑ=90º correspond with the circumferential and longitudinal directions, 
respectively. Fiber undulation (𝑢) is defined as the ratio between the path length (𝑙𝑝) and 
the end-to-end length (𝑙𝑒) of a given fiber.  
𝑢 =  
𝑙𝑝
𝑙𝑒
  (3.6) 
3.3.13 Collagen Content by Light Microscopy 
LV septal and lateral sections were stained with picrosirius red (PSR) and viewed 
with polarized light at a magnification of 40x. Five fields were chosen at random from the 
mid-myocardium. Fields with large blood vessels were excluded from the analysis. 
Collagen volume fraction (CVF) was calculated as the area stained by PSR divided by the 
total area of interest using ImageJ software.126 
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3.3.14 Statistical Analysis 
Data are reported as the mean ± standard error of the mean. Comparative analyses 
were performed using a one-way analysis of variance followed by pair-wise comparisons 
using the least significant difference post hoc study. For the assessment of the relative 
change from baseline, a t-test was performed whereby significance of the transformed data 
were determined using a null hypothesis of a zero-mean value. For SHG collagen fiber 
characterization, at each timepoint, all values of φ, ϑ, and 𝑢 were pooled and binned into 
100 equally sized bins. The resulting frequency distributions were subjected to a Kruskal-
Wallis one-way analysis of variance for non-parametric comparisons across different 
timepoints. A multiple linear regression model with inputs derived at one-week post-PO 
was used to predict the relative change in 𝐾𝐶
∗ at two-weeks, three-weeks, four-weeks, and 
five-weeks post-PO, and the p-value and t-statistic were calculated for each of the input 
variables. A Spearman’s rank correlation analysis was used to interrelate experimental 
response variables at four- and five-weeks post-PO. All statistical analyses were performed 
with SPSS software (version 24.0, SPSS Inc) or MATLAB (version R2018a, The 
MathWorks Inc). A p-value of less than 0.05 was considered statistically significant. 
 
3.4 RESULTS 
3.4.1 Left Ventricular Geometry and Systolic Function 
The progressive hydraulic inflation of the aortic cuff resulted in significant 
hypertrophy of the LV as compared to an age-matched referent control LV as a result of 
the narrowing of the aortic lumen (Figure 3.1A). This hypertrophic response, growth that 
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superseded that which can be expected due to normal growth, occurred in a time-dependent 
fashion over five weeks (Figure 3.1B). In contrast, the ratio of LV EDV to body weight 
was preserved and systolic function, assessed by LV ejection fraction, was modestly 
increased relative to baseline at both four- and five-weeks post-PO. Significant increases 
in the LV mass/volume ratio and LA area were observed. The effects of PO on LV function 
and geometry are summarized in Figure 3.2. 
3.4.2 Left Ventricular Diastolic Function 
Following established convention, chamber stiffness was determined from 
pressure-volume relations at the four- or five-week post-PO terminal timepoint and age-
matched referent control pigs (Figure 3.3A). Significant increases in chamber stiffness 
were observed in the banded animals (Figure 3.3B). Similarly, increases in the previously-
defined non-invasive surrogate for chamber stiffness (𝐾𝐶
∗) were observed in the banded 
animals relative to baseline observations by one-week post-PO and progressive increases 
through five-weeks post-PO. Post-processing via Pearson correlation analysis yielded 
significant correlation between these two measurements of chamber stiffness (ρ=0.75, 
p<0.05). As such, for the duration of the results and discussion, we will use 𝐾𝐶
∗ as the 
predominant measure of LV chamber stiffness because it can be measured in a serial 
manner. 
3.4.3 Left Ventricular Collagen Content and Organization 
Photomicrographs of picrosirius red-stained slides enabled quantification of 
myocardial collagen content (Figure 3.4). CVF was indistinguishable at four- versus five-
weeks post-PO, but both were more than doubled compared to the referent control value. 
The increase in collagen content was coupled with significant changes in collagen fiber 
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microstructure (Figure 3.5). In all three layers of the LV, observed fiber undulation 
distributions indicated a significantly higher coincidence of less wavy fibers at five-weeks 
post-PO compared to referent control (Figure 3.5B). In terms of ECM organization, 
collagen fiber angle distributions on the circumferential-longitudinal plane in the 
epicardium and endocardium were significantly shifted towards the circumferential axis by 
five weeks and four weeks post-PO, respectively (Figure 3.5C). Collagen fiber angle 
distributions on the radial-longitudinal plane were mostly preserved during the five weeks 
of this study (Figure 3.5D). 
3.4.4 Assessment of Biomechanical Behavior and Properties 
STE was used to serially track LVPO-induced changes in regional peak strain, 
diastolic strain rate, and diastolic myocardial stiffness (Figure 3.6). Peak strain, taken as 
an index of regional systolic function, is generally preserved in the longitudinal direction 
and moderately elevated in the circumferential direction by one-week post-PO. Regional 
diastolic function, assessed via diastolic strain rate, was found to be impaired in the 
longitudinal direction with a reduction relative to baseline values observed in the 
endocardium and mid-myocardium by three-weeks or four-weeks post-PO, respectively. 
In contrast, circumferential diastolic strain rate was mostly preserved. LVPO was found to 
have a significant effect on diastolic myocardial stiffness in both the circumferential and 
longitudinal directions. Regional measurements of diastolic myocardial stiffness were 
validated against the measurements obtained from the invasive catheterization 
measurements defined above and a significant correlation between the two was observed 
(ρ=0.70, p<0.05). The global diastolic myocardial stiffness, taken as the average stiffness 
computed among all defined regions, significantly increased by four-weeks post-PO in the 
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circumferential direction and by two-weeks post-PO in the longitudinal direction, with 
progressive increases subsequently occurring in both directions. 
3.4.5 Correlation Between Regional Composition and Biomechanical Behavior and 
Properties 
A correlation matrix was developed to relate the relative change in biomechanical 
response metrics and geometrical, compositional, and microstructural features of the 
myocardium at the terminal study timepoints (Figure 3.7). Surprisingly, subject-specific 
changes in wall thickness and collagen content did not significantly correlate with the 
changes in biomechanical response metrics, while ECM microstructure did so in an 
intuitive manner. Specifically, a reduction in fiber undulation (𝑢→1) was correlated with 
increased myocardial stiffness in all three layers of the LV. Furthermore, an inverse 
correlation was observed between the elevation angle and myocardial stiffness – linking a 
preferential fiber orientation towards the circumferential axis (ϑ→0°) to higher 
circumferential myocardial stiffness. 
3.4.6 Predicting Changes in LV Chamber Stiffness 
To develop an index of biomechanical adaptation of the myocardium to LVPO, we 
examined the subject-specific relationship between regional changes in diastolic 
myocardial stiffness and wall thickness. Specifically, we computed the slope of a linear 
regression in the circumferential stiffness-thickness plane (𝜕𝐾𝑀𝑅/𝜕𝐻) developed with 
measurements from the six defined myocardial regions at one-week post-PO (Figure 
3.8A). The observed inverse relationship, when computed for an individual subject, is 
posited as an index of adaptation in the sense that the more negative the slope, the more 
the myocardium has mechanically-compensated for increased wall thickness such that the 
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concomitant increase in 𝐾𝐶
∗ is less severe. This index of adaptivity was combined with the 
measurement of the current chamber stiffness (𝐾𝐶,1−𝑤𝑒𝑒𝑘
∗ ) in a multiple linear regression 
model of the form: 
𝐾𝐶,𝑝𝑟𝑒𝑑.
∗ = 𝑎
𝜕𝐾𝑀𝑅
𝜕𝐻
+ 𝑏(𝐾𝐶,1−𝑤𝑒𝑒𝑘
∗ ) + 𝑐(𝑇) + 𝑑, (3.7) 
where 𝑎, 𝑏, 𝑐, and 𝑑 were fitting parameters and 𝑇 was the time (in days) of the 
echocardiographic analysis after the initial placement of the aortic cuff. A post-hoc Pearson 
correlation analysis of the predicted change in chamber stiffness versus the experimentally 
measured result demonstrates a strong correlation between the two numbers (Figure 3.8B) 
(ρ=0.75, R2=0.57, p<0.05). After the determination of the t-statistic for each of the four 
fitting coefficients, all were deemed to be statistically significant with a significance level 
of 5% (0.05). 
 
3.5 DISCUSSION 
3.5.1 Study Overview 
The clinical syndrome of HFpEF burdens over three million patients in the United 
States alone and carries a five-year mortality rate of approximately 50%.30,31,127 While there 
are viable pharmacological and therapeutic options available for those suffering from 
HFrEF, HFpEF treatments are limited by our poor understanding of disease phenotype, 
etiology, and progression.51,92–100 The present study seeks to address this knowledge gap 
with a series of regional measurements of myocardial mechanics and microstructure in a 
porcine model of LVPO with retained systolic function. Using a combination of non-
invasive serial measurements and ex-vivo analysis, the significant and noteworthy findings 
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from this study were three-fold. First, our results show that in addition to the expected 
increase in LV 𝐾𝐶
∗, progressive changes in regional diastolic myocardial stiffness occur 
over five-weeks post-PO and provide a promising basis for improved clinical phenotyping 
of HFpEF. Second, elevated myocardial stiffness following LVPO is modulated by not 
only increased collagen content, but also changes in collagen fiber alignment and 
undulation. Third, through pig-specific analysis of regional changes in myocardial stiffness 
and wall thickness shortly following the onset of LVPO, we have identified a novel method 
to predict the extent of adverse LV chamber stiffening observed at later times post-PO. 
Thus, using a pre-clinical model we have shown the viability of serial biomechanical 
analysis as a basis to track the progression of HFpEF and present a translational method to 
stratify patient risk and assess the efficacy of pharmacological and therapeutic approaches. 
3.5.2 Serial Tracking of Myocardial Biomechanics and Mechanical Properties 
While the progression of HFpEF can be difficult to assess and track in a clinical 
setting, this animal model resulted in LV hypertrophy and hallmark characteristics of 
HFpEF in accord with previous studies.109 From a biomechanical perspective, hypertrophy 
is the primary adaptive response of the myocardium to LVPO that mitigates the 
concomitant increase in wall stress.128,129 Partially as a result of hypertrophy, progressive 
and significant elevations in diastolic 𝐾𝐶
∗ also occur over the time course of this study – 
again falling in line with a multitude of prior studies.47,109,114,115,130,131 However, a 
comparison of late study time points (four- versus five-weeks post-PO) suggests that 
structural stiffness elevations are not simply governed by the addition of myocardial mass, 
but also the local mechanical stiffening of the myocardium itself.  While the co-dependence 
of aberrant LV structural mechanics on both myocardial geometry and mechanical 
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properties is expected in all modes of HF, our results provide novel directional and regional 
detail on PO-induced elevations in diastolic myocardial stiffness (KMR) and, importantly, 
inform temporal relation to elevations in 𝐾𝐶
∗.18,109,130,132,133  Despite the substantial changes 
in geometry, KMR, and 𝐾𝐶
∗, baseline peak strain and diastolic strain rate were largely 
retained. While there are a number of recent clinical studies which suggest that HFpEF is 
marked by a reduction of global longitudinal strain, this study (along with others) shows 
modest, if any, early changes in regional or global strain and diastolic strain rate. This 
finding suggests that global longitudinal strain values may be used to sub-classify HFpEF 
in the early stages of disease progession.111,134–137   
3.5.3 Microstructural changes with LVPO 
A consensus has emerged that the extracellular matrix (ECM) is extensively altered 
in the case of HFpEF secondary to LVPO.138 These changes, primarily excessive ECM 
deposition by fibroblasts and changes in the relative balance between matrix 
metalloproteinases (MMPs) and the tissue inhibitors of the MMPs, are not readily 
reversible and contribute to impaired diastolic function.138–142 This excessive ECM 
deposition, most notably increased collagen content, has been associated with the 
progressive stiffening of the LV and myocardium.143–146 While we too observe LVPO-
induced increases in CVF, correlation analyses suggest that changes in collagen fiber 
microstructure further modulate myocardial stiffness at later post-PO time points. As first 
established in the context of vascular mechanics, the inherent undulation of tissue-
embedded collagen fibers implies a gradual contribution to load-bearing under increasing 
tension.147 Likewise in the myocardium, a collagen fiber with relatively less undulation  
will be recruited to load-bearing at relatively lower loads (pressure), and thus lead to 
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increased KMR. Our regional analysis indeed showed correlation between the reductions in 
fiber undulation and increases in KMR. We posit that in the cycle of degradation and 
synthesis of collagen that occurs secondary to LVPO, the newly deposited collagen is 
embedded in the ECM under a higher degree of tension due to the elevated intraventricular 
pressure, which in turn reduces mean undulation and increases passive stiffness. We also 
show significant collagen fiber realignment concordant with disease progression. Much 
like previously reported findings of the infarcted myocardium, we observe that LVPO-
induced hypertrophy is associated with an increased circumferential alignment of collagen 
fibers.34 Taken together, these findings suggest that changes in fiber microstructure and 
alignment contribute to the recorded elevations in both circumferential and longitudinal 
KMR. 
3.5.4 Early Stratification of Subject-Specific Risk 
It is accepted that soft tissue growth and remodeling are adaptive responses to cope 
with sustained changes in the local mechanical environment (i.e. stresses and strains) of 
mechanosensitive cells.148–151 In 1995, Fung proposed a kinematic mass-stress relationship 
with the fundamental idea that every biological tissue has mechanisms by which to 
maintain a certain homeostatic stress state.152 Thus, elevations in stress (possibly due to 
increased loading) would result in a compensatory increase in mass, while reductions in 
stress would result in the opposite – effectively restoring the tissue to its native homeostatic 
stress state. While modulation of growth facilitates the maintenance of the local 
homeostatic stress state, we posit that in an optimally adaptive tissue, local changes in mass 
must also be coupled with proportionally opposing changes in local stiffness so as to 
maintain structural compliance. As it applies to the present study, at one-week post-PO, we 
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observed that local wall thickening coincides with relatively less local stiffening (or even 
reductions in local stiffness) throughout the myocardium. Based on this notion of optimal 
adaptation, we take the degree to which an inverse thickening-stiffening relation is manifest 
to reflect the overall LV adaptive capacity of the individual subject. We defined a related 
index of biomechanical adaptation and showed that it, along with 𝐾𝐶
∗ also obtained at this 
early time point, can be used to predict subsequent elevations in 𝐾𝐶
∗ (Figure 3.7). Though 
it does little to address the underlying mechanisms, the proposed model may prove to be a 
clinically-relevant means to predict an individual patient’s progression to HFpEF and 
therefore may influence clinical decision making in regard to disease prevention or 
management.50,116–119 Furthermore, these findings give rise to a potential target for future 
studies as we seek to understand the epidemiological mechanisms which drive the varying 
degrees of biomechanical adaptive capacity on a subject-to-subject basis. 
3.5.5 Study Limitations and Summary 
For the first time, a serial characterization of myocardial mechanics and the 
organization/configuration of collagen within the ECM has been performed in a large 
animal model of LVPO. Furthermore, we present a novel mechanics-based method to 
predict the subject-specific severity of LV chamber stiffening, a central component of the 
HFpEF phenotype. However, several study limitations should be considered upon 
evaluation of our conclusions. Firstly, although the porcine model employed in our study 
enabled unique measurements with potential to advance the phenotyping of HFpEF, this 
animal model does not emulate any of the co-morbidities typically observed in patients 
with HFpEF (i.e. metabolic or renal dysfunction). Additionally, while the indices of 
diastolic dysfunction (i.e. LA area, LV chamber stiffness) suggest that these animals are 
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on a trajectory to HFpEF, the study was completed prior to a robust symptomatic 
development of HFpEF. Finally, while this study provides a promising method to predict 
HFpEF progression based on early observations of LV biomechanics, we did not explore 
the extent to which our results/predictions would vary in the context of a therapeutic 
intervention. Future studies in a clinical setting would be needed to further validate our 
findings and importantly evaluate the translational potential of using early changes in LV 
biomechanics following the onset of LVPO to predict those patients at greatest risk for the 
development and progression of HFpEF. 
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 3.7 FIGURES
Figure 3.1: Pressure overload-induced hypertrophy of the LV 
(A) Representative transthoracic echocardiographic views of the LV short-axis at the 
level of the papillary muscle along with preserved bisections of the intact ventricles and 
ascending aorta for both study groups. A clear and obvious thickening of the LV 
occurred as a result of LVPO. The aortic cuff significantly reduced the cross-sectional 
area of the aortic lumen. (B) LV mass obtained at baseline and over five-weeks post-
PO superimposed on a normogram of LV mass relative to body weight. The observed 
increase in LV mass indicates a pressure-induced hypertrophic response. (BL – three-
weeks post-PO: n=15; four-weeks post-PO: n=14; five-weeks post-PO: n=7) 
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Figure 3.2: Echocardiographic indices of the progression to HFpEF. 
(A) Baseline values of LV end-diastolic volume/body weight ratio, (B) LV ejection 
fraction, (C) LV mass/volume ratio were largely maintained over the study period, and 
(D) LA Area progressively increased over five-weeks post-PO. * p<0.05 vs. baseline 
value, + p<0.05 vs. one-week value, # p<0.05 vs. two-weeks value, ‡ p<0.05 vs. three-
weeks value. (BL – three-weeks post-PO: n=15; four-weeks post-PO: n=14; five-weeks 
post-PO: n=7) 
 
  
 
71 
 
0
50
100
150
200
0 10 20 30 40
L
V
 P
re
s
s
u
re
 (
m
m
H
g
)
LV Volume (mL)
0
50
100
150
200
0 10 20 30 40
L
V
 P
re
s
s
u
re
 (
m
m
H
g
)
LV Volume (mL)
(A)
(B)
(C)
0
0.05
0.1
0.15
0.2
0.25
0.3
0
1
2
3
4
5
6
7
8
Referent
Control
4-5 Weeks
Post-PO
* *𝐾𝐶
𝐾𝐶
∗
C
h
a
m
b
e
r 
S
ti
ff
n
e
s
s
, 
𝐾
𝐶
C
h
a
m
b
e
r 
S
ti
ff
n
e
s
s
, 
𝐾
𝐶∗
0
5
10
15
20
12 20 28 36
L
V
 P
re
s
s
u
re
 (
m
m
H
g)
LV Volume (mL)
0
5
10
15
20
12 20 28 36
L
V
 P
re
s
s
u
re
 (
m
m
H
g)
LV Volume (mL)
0
20
40
60
80
100
120
140
1 2 3 4 5
𝐾
𝐶∗
(%
 C
h
a
n
g
e
 f
ro
m
 B
a
s
e
lin
e
)
*
*
*+
*+
*+#‡§
Weeks (Post-PO)
Figure 3.3: Evaluation of left ventricular chamber stiffness. 
(A) Gold-standard techniques were used to derive measurements of left ventricular 
chamber stiffness in a subset of referent control (n=5) and pigs four- or five-weeks post-
PO (n=5) from pressure-volume relationships. A significant reduction in LV chamber 
compliance was observed in the animals four- to five-weeks post-PO – as evidenced by 
the included representative examples. (B) A non-invasive surrogate of LV chamber 
stiffness (𝐾𝐶
∗) was generated and validated against the gold-standard measurements of 
chamber stiffness. While differing in magnitude, a correlative response was observed 
between the two measurements. (C) This non-invasive measurement of chamber 
stiffness allows for the serial assessment of diastolic function and demonstrates 
progressive stiffening of the LV chamber through the five weeks of the study. * p<0.05 
vs. baseline value, + p<0.05 vs. one-week value, # p<0.05 vs. two-weeks value, ‡ p<0.05 
vs. three-weeks value, § p<0.05 vs. four-weeks value. (BL – three-weeks post-PO: n=15; 
four-weeks post-PO: n=14; five-weeks post-PO: n=7) 
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Figure 3.4: Quantification of collagen content. 
(A) Transmural sections of the LV mid-myocardium were stained with picrosirius red 
and imaged at 40x magnification. (B) Collagen volume fraction (CVF) was computed 
for samples corresponding to referent control (n=7), four-weeks post-PO (n=6), and 
five-weeks post-PO (n=7). * p<0.05 vs. referent control value. 
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Figure 3.5: Characterization of collagen fiber structure and orientations. 
(A) Three-dimensional stacks of two-dimensional images acquired from second 
harmonic generation enabled reconstruction of collagen fibers and subsequent 
representation as vectors in a Cartesian coordinate system for samples corresponding to 
referent control (n=5), four-weeks post-PO (n=6), and five-weeks post-PO (n=7). (B) 
Regional fiber undulation (𝑢) distributions were computed for the epicardium (EPI), 
mid-myocardium (MYO), and endocardium (ENDO) based on reconstructed fiber 
geometries. Two fiber-specific angles were computed to quantify fiber orientation. (C) 
The elevation angle, ϑ, was computed from the circumferential-longitudinal plane. An 
angle of ϑ=0° indicates fiber alignment with the circumferential axis. (D) The azimuthal 
angle, φ, was computed from the longitudinal-radial plane. An angle of φ=0º indicates 
fiber alignment with the radial axis. * p<0.05 vs. referent control value, § p<0.05 vs. 
four-weeks value. 
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Figure 3.6: Biomechanical response and properties. 
Peak strain (left column) and diastolic strain rate (middle column) underwent similar 
changes in the epicardium, mid-myocardium, and endocardium over five weeks post-
PO. The mean regional diastolic myocardial stiffness (|𝜅𝑀𝑅| right column) was found 
to progressively increase over five-weeks post-PO in both the circumferential and 
longitudinal directions. * p<0.05 vs. baseline value, + p<0.05 vs. one-week value, 
‡ p<0.05 vs. three-weeks value. (BL – three-weeks post-PO: n=15; four-weeks post-PO: 
n=14; five-weeks post-PO: n=7) 
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Figure 3.7: Biomechanical, geometrical, compositional, and microstructural 
correlations. 
A Spearman’s rank correlation analysis was used to interrelate region-matched 
biomechanical response variables (peak strain, diastolic strain rate, and diastolic 
myocardial stiffness (KMR)) with geometrical (wall thickness), compositional (collagen 
volume fraction (CVF)), and microstructural (collagen undulation (𝑢) and orientation 
(ϑ and φ)) response variables. All correlations refer to the terminal study timepoint 
(four-weeks post-PO: n=6; five-weeks post-PO: n=7). * p<0.05 for Spearman’s rank 
correlation coefficient (ρ). (EPI: epicardium; MYO: mid-myocardium; ENDO: 
endocardium) 
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Figure 3.8: A method for predicting the late PO-induced increase in LV chamber 
stiffness based on early measurements of LV geometry, local material stiffness, 
and LV chamber stiffness. 
(A) Region-matched changes in wall thickness and circumferential diastolic myocardial 
stiffness obtained at one-week post-PO (𝐾𝑀𝑅), reported as the mean values among all 
animals (n=14) in the circumferential direction. The observed inverse correlation is 
indicative of adaptive remodeling that mitigates increased wall stress with PO, whereby 
we propose the degree of subject-specific adaptivity is related to the degree to which 
local wall thickening is compensated for by a relatively muted increase in local diastolic 
myocardial stiffness. (B) A predicted value for changes in LV chamber stiffness relative 
to baseline (𝐾𝐶,𝑝𝑟𝑒𝑑.
∗ ) at three-weeks, four-weeks, and five-weeks post-PO was 
generated through multiple linear regression modeling of subject-specific response 
variables using LV chamber stiffness (𝐾𝐶
∗) and (𝜕𝐾𝑀𝑅/𝜕𝐻) taken at one-week post-PO 
as input variables. 𝐾𝐶,𝑝𝑟𝑒𝑑.
∗  significantly correlated with the experimentally measured 
values, suggesting that measurements obtained at one-week post-PO can predict the 
severity of subsequent LV chamber stiffening. 
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CHAPTER 4 
 
ECHOCARDIOGRAPHIC QUANTIFICATION OF THE PASSIVE 
MECHANICAL PROPERTIES OF THE LEFT VENTRICULAR 
MYOCARDIUM  3 
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4.1 ABSTRACT 
Advancing assessment of the rate and extent of left ventricular (LV) remodeling 
holds great value for heart failure (HF) diagnosis and prognosis. While global longitudinal 
myocardial strain determined by speckle-tracking echocardiography (STE) has been 
considered as a remodeling response variable, reported strain measures are limited by the 
masking of regional differences and a dependency on hemodynamic load. Our study entails 
a novel extension of two-dimensional STE to quantify the regional passive mechanical 
properties of the LV myocardium – providing a clinically accessible, load-independent 
response variable that reflects the LV remodeling process. An inverse finite element 
analysis was employed with a pattern search optimization algorithm to identify regional 
indices of passive myocardial stiffness based on STE-derived regional longitudinal strains 
and wall geometries. Our framework was applied in two distinct porcine models of early 
LV remodeling, specifically following myocardial infarction and onset of LV pressure 
overload. Obtained results elucidate regional and temporal changes in passive myocardial 
stiffness throughout early LV remodeling in both animal models. Changes in passive 
myocardial stiffness demonstrate enhanced sensitivity as compared to changes in global 
strain, and strongly correlate with conventional indices of LV remodeling. Regional 
passive myocardial stiffness can be noninvasively determined via STE data processing 
using an inverse finite element framework and provides a sensitive index of LV remodeling 
with potential to aid in HF diagnosis and prognosis. 
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4.2 INTRODUCTION 
Heart failure (HF) is a clinical syndrome which most commonly arises from two 
potentially overlapping physiological causes: impaired left ventricular (LV) ejection 
performance or impaired LV filling. In terms of HF phenotyping, impaired LV ejection 
performance is defined as HF with reduced ejection fraction (HFrEF) while impaired LV 
filling with a stable ejection performance is defined as HF with preserved ejection fraction 
(HFpEF). These HF phenotypes emerge from distinctly different etiologies, whereby 
HFrEF commonly occurs secondary to myocardial injury/ischemia and HFpEF arises from 
a chronic LV pressure overload such as hypertension. In both HFrEF and HFpEF, the LV 
undergoes progressive changes in geometry, composition, and mechanical properties 
collectively known as LV remodeling.52,56,153–156 While nominally an adaptive response, 
LV remodeling underlies HF progression, and consequently its serial assessment holds 
great value in HF diagnosis and prognosis.157–160 
Although commonly used in a clinical setting, global measures of LV function such 
as ejection fraction or volumes can be insensitive to early changes in LV performance and 
thus fail to identify HF development and progression. Alternatively, the assessment of 
regional function through the quantification of LV myocardial strain, defined as the 
fractional change in length of a myocardial segment relative to its baseline length, has 
gained traction recently as a comparatively sensitive index of LV remodeling.161 
Developments in ultrasound-based imaging technology enable serial quantification of LV 
myocardial strain in a clinical setting. Specifically, speckle-tracking echocardiography 
(STE) tracks segmental length changes via the relative movement of intrinsic acoustic 
markers of the LV to quantify regional myocardial strain.7 The analysis of both global 
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(fractional change in total segmental length) and regional longitudinal strain using STE can 
provide diagnostic information in disease states ranging from myocardial infarction to 
cardiotoxicity.64,65,122,134,137  
Despite the demonstrated clinical utility of STE for the assessment of LV 
remodeling, there are clear factors limiting its clinical adoption.162 Firstly, most clinical 
use of STE has been focused on global longitudinal strain despite the availability of 
regional measures – significantly narrowing the field of diagnostic information by masking 
potentially distinct regional changes.161,163,164 Secondly, obtained strain measurements are 
highly dependent on hemodynamics (e.g. blood pressure, heart rate) and assumptions used 
to calculate LV wall geometry.165,166 Not fully accounting for these factors diminishes the 
value of serial STE-based measurements and inter-subject comparisons. 
The objective of the current study is to minimize the load-dependency of STE-
based measurements and more effectively leverage the full field of speckle data to assess 
LV remodeling.  To this end, we integrate STE-derived measures of regional LV geometry 
and myocardial strain along with an estimation of the mechanical load (i.e. ventricular 
pressure) within an inverse finite-element framework to compute regional passive 
myocardial mechanical properties. STE data from porcine models of both ischemia 
reperfusion and LV pressure overload are processed in our inverse framework to generate 
spatiotemporal maps of a passive myocardial stiffness index and the diastolic myocardial 
stress throughout early LV remodeling.  
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4.3 MATERIALS AND METHODS 
4.3.1 Large Animal Models of HFrEF and HFpEF 
For both models of LV failure, mature pigs (Yorkshire, 20-22 kg) were utilized 
whereby HFrEF was induced by intracoronary induction of ischemia-reperfusion while 
HFpEF was induced by LV pressure overload due to progressive ascending aortic 
stenosis.73,109 Briefly,  for the HFrEF protocol, the pigs (n=8) were anesthetized (isoflurane, 
3%/1.5L/min; nitrous oxide, 0.5L/min) and an angioplasty balloon catheter (5F Launcher 
guiding catheter, 0.058-in. HIS, Medtronic, Minneapolis, MN) was placed within the left 
anterior descending artery, immediately below the first obtuse marginal branch, under 
fluoroscopic guidance (Arcadis Varic C-Arm, Siemens, Munich, DE). After 90 minutes of 
coronary occlusion, the balloon was deflated and the catheter system was removed. This 
approach resulted in a reproducible apical anterior myocardial infarction, and over time a 
reduction in LV ejection fraction (LVEF) – thus recapitulating the HFrEF phenotype.73,122 
For HFpEF induced by LV pressure overload, pigs (n=9) were anesthetized as described 
above, and the ascending aorta accessed through a left thoracotomy. An inflatable silastic 
vascular cuff (12mm, Access Technologies, Skokie, IL) was secured around the 
supracoronary ascending aorta and connected to a subcutaneous access port. Serial 
hydraulic-mediated cuff inflation was initiated following a one-week recovery period, in 
which the cuff was inflated through the access port (via 0.45 mL glycerol) to achieve a 
specific target gradient of 75 mmHg across the cuff and induce LV pressure overload. At 
weekly intervals thereafter, the cuff was further inflated (0.25 mL increments) to cause a 
stepwise increase in the pressure gradient (25 mmHg increase/inflation).  
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All animals were treated and cared for in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals (Eighth Edition. Washington, 
DC: 2011) and all experimental protocols were approved by Institutional Animal Care and 
Use Committees at the University of South Carolina. 
4.3.2 Serial Echocardiographic Studies   
The day before animals underwent either coronary occlusion or placement of the 
aortic cuff, the pigs were sedated (diazepam, 200 mg), placed in a custom-designed sling, 
and transthoracic echocardiographic studies were performed (GE Vivid E9 with XDclear 
Ultrasound System; M5S (3.3 MHz, 40 FPS) transthoracic probe). Two-dimensional 
echocardiographic cine loops were acquired from a transthoracic right parasternal 
approach. The left atrium (LA) and LV were imaged in both the short- and long-axis views. 
Pulse-wave and tissue Doppler studies were performed to determine flow velocities and 
pressure gradients.167 
 The pigs were then returned to the laboratory for follow-up imaging studies 
under identical conditions and approaches, whereby the HFrEF pigs were returned for 
imaging studies at 14 and 28 days post-coronary occlusion and the HFpEF pigs were 
returned to the laboratory at 7, 14, 21, and 28 days for both imaging studies and serial 
hydraulic-mediated expansion of the aortic cuff under echocardiographic guidance and 
sterile conditions as described previously.109 
4.3.3 Post-Acquisition Analysis of LV Function and Geometry 
The digital echocardiographic images were transferred to a workstation for offline 
analysis (EchoPac, Vingmed, GE). LV end-diastolic volume (EDV) and LVEF were 
calculated using the biplane method of disks. LA area was determined from the 
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anteroposterior dimensions acquired from the parasternal long axis view. For each digital 
loop, a region of interest (ROI) was defined at the onset of the R-wave by manually 
identifying the endocardial and epicardial borders. The ROI was then discretized with a 
spatial mesh of acoustic clusters to be tracked on a frame-to-frame basis throughout a single 
cardiac cycle.7 Quantitative strain analysis (Q-analysis) was performed, regional tracking 
quality was assessed, and the ROI was manually adjusted by the operator to improve 
tracking quality where necessary. Successful tracking of the ROI allowed for the definition 
of segmental lengths which were computed at end-diastole (L0) and continuously 
throughout the cardiac cycle (L). Segmental strains (𝜀) were then computed as: 
𝜀 =
𝐿−𝐿0
𝐿0
=
∆𝐿
𝐿0
,  (4.1) 
where the reference length refers to the end-to-end length in the longitudinal direction of a 
particular echocardiographic segment (i.e. basal posterior, mid posterior, apical posterior, 
apical anterior septum, mid anterior septum, or basal anterior septum) or, in the case of 
global longitudinal strain, the end-to-end length of the mid-myocardium in the longitudinal 
direction (i.e. from the basal posterior, to the apex, and then to the basal anterior septum). 
Subsequently, spatial coordinates of the mid-myocardial nodes were exported for each 
frame of the digital loop. Additionally, wall thickness was collected at early- and end-
diastole for each of the six conventional echocardiographic segments. Pulmonary capillary 
wedge pressure (PCWP) was subsequently calculated using the method proposed by 
Nagueh et al in 1997.168 
4.3.4 Formulation of the Finite-Element Mesh 
The initial, unloaded, LV configuration was generated from the position of the mid-
myocardial nodes at the onset of diastole, the point at which the cross-sectional area was 
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at a minimum. For each mid-myocardial node, a thickness was defined by computing a 
cubic spline interpolation between the known thicknesses at the onset of diastole of the six 
echocardiographic segments. Endocardial and epicardial nodes were subsequently 
generated based on the position of the mid-myocardial nodes and estimated thicknesses. 
The finite-element mesh was constructed from this reference geometry composed of a 
monolayer of eight-node trilinear hexahedral elements with two elements spanning the 
distance between each of the mid-myocardial nodes and eight elements spanning the 
distance between the pairs of endocardial and epicardial nodes (Figure 4.1A-C). This 
process was also completed for the end-diastolic configuration to enable calculation of the 
objective function as detailed below (Figure 4.1D-F).  
4.3.5 Material Model and Boundary Conditions 
The LV myocardium was modeled as a transversely isotropic Mooney-Rivlin solid, 
a model well-suited for biological soft tissues with a preferred fiber direction.169 The 
uncoupled strain energy function is: 
𝑊 = 𝐹1(𝐼1̃, 𝐼2̃) + 𝐹2(?̃?) +
𝐾
2
[ln(𝐽)]2, (4.2) 
where 𝐾 is the bulk modulus-like penalty parameter and 𝐽 is the determinant of the 
deformation gradient tensor. The function 𝐹1(𝐼1̃, 𝐼2̃), a function of the first and second 
invariants of the deviatoric right Cauchy-Green deformation tensor, represents the material 
response of the isotropic Mooney-Rivlin ground substance matrix of the form: 
𝐹1(𝐼1̃, 𝐼2̃) = 𝑆[𝐶1(𝐼1̃ − 3)] + 𝑆[𝐶2(𝐼2̃ − 3)] +
𝐾
2
[ln(𝐽)]2  (4.3) 
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where 𝐶1 and 𝐶2 are the material coefficients and 𝑆 is the regional stiffness index. 𝐹2(?̃?), 
a function of the fiber stretch ratio, represents the contribution from the fiber family with 
a strain energy of the following form: 
𝐹2(?̃?) = {
0 ?̃? ≤ 1
𝐶3 [𝑒
−𝐶4 (𝐸𝑖(𝐶4?̃?) − 𝐸𝑖(𝐶4)) − ln ?̃?] 1 < ?̃? < 𝜆𝑚
𝐶5(?̃? − 1) + 𝐶6 ln ?̃? ?̃? ≥ 𝜆𝑚
 (4.4) 
where 𝐶3 scales the exponential term, 𝐶4 is the fiber crimping coefficient, 𝐶5 is the modulus 
of the straightened fibers, and 𝜆𝑚 is the stretch at which the fibers are straightened. 
Furthermore, 𝐸𝑖(∙) is the exponential integral function and 𝐶6 is determined from stress 
continuity requirements. The fiber orientation was specified for each element to be 15º 
relative to the longitudinal axis on the longitudinal-radial plane with a 𝜆𝑚 of 1.10. The 
remaining material parameters, barring the regional stiffness index, were valued in 
accordance with prior work on biaxial testing on excised canine hearts.17 The regional 
stiffness index, 𝑆, was determined from the optimization scheme described in the following 
section. 
Two quasi-static structural mechanics steps were defined as follows. In step one, a 
prescribed translation was applied to the basal nodes from the undeformed configuration 
to the expected position at end-diastole as determined from STE. In step two, the basal 
node positions were fixed, and the end-diastolic pressure was applied to the endocardial 
surface.170 To mimic the tethering effects of the right ventricle and the pericardium, an 
opposing pressure was applied to the basal and mid-ventricular epicardial nodes with a 
magnitude of 25% of that of the intraventricular pressure.171,172 The solution was computed 
using the PARDISO linear solver within the FEBio application.173,174 
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4.3.6 Identification of Material Properties 
An objective function (𝛱) of the form: 
𝛱 = (
𝐴′−𝐴
𝐴
+ ∑ (
𝜀𝑖
′−𝜀𝑖
𝜀𝑖
)6𝑖=1 +
𝑡′̅−?̅?
?̅?
) × 100% (4.5) 
was developed as a function of the actual end-diastolic area (𝐴), regional strain (𝜀𝑖) relative 
to the undeformed mesh, and mean wall thickness (𝑡̅) determined from the end-diastolic 
mesh (Figure 4.1F). Additionally, 𝐴′, 𝜀𝑖
′, and 𝑡′̅ represent the end-diastolic area, regional 
strain relative to the undeformed mesh, and mean wall thickness computed from the 
deformed FE model, respectively. The factors entering the optimization scheme were the 
stiffness indices (𝑆) defined at the center of each of the six conventional anatomical 
segments of the LV. A cubic spline interpolation was used to define a continuous 
distribution of stiffness indices between the six segments. A pattern search optimization 
algorithm, ideal for the minimization of a non-differentiable objective function, was 
employed to identify an optimal set of stiffness indices coincident with the global minimum 
of the objective function. The pattern search algorithm was terminated when a successful 
poll resulted in a change in the objective function of less than 1E-6 (Figure 4.2).  
The optimization process was conducted on a workstation with an eight-core 
processor (3.7 GHz) and 32 GB of RAM. After optimization was complete, a final 
simulation with a refined FE mesh and assigned regional values of S was performed, thus 
facilitating the calculation of the first principal stress field. 
4.3.7 Statistical Analysis 
Data are reported as the mean ± standard error of the mean. Comparative analyses 
between the two groups were performed using a two-way analysis of variance followed by 
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pair-wise comparisons using the least significant difference post hoc study. A Pearson 
correlation analysis was used to interrelate classical echocardiographic indices with those 
derived from regional inverse analyses. A p-value of less than 0.05 was considered 
statistically significant. All statistical analyses were performed in MATLAB (version 
R2018a, The MathWorks Inc). 
 
4.4 RESULTS 
4.4.1 Left Ventricular Function and Geometry 
LV function and geometry at baseline and at the two specified time points (14 and 
28 days) are shown in Table 4.1. In the HFrEF group, LVEF was reduced and LV dilation 
occurred; consistent with the HFrEF phenotype. In the HFpEF group, LVEF and LV 
volume were unchanged, whereas LA area increased; consistent with the HFpEF 
phenotype. Spatial mapping of regional LV longitudinal strain showed an overall reduction 
in the HFrEF group, with the greatest reductions occurring in the mid- and apical-anterior 
regions. In marked contrast, regional LV longitudinal strain remained comparatively 
preserved in the HFpEF group (Figure 4.3A). Global LV longitudinal strain fell by 
approximately 50% from baseline at both 14 and 28 days in the HFrEF group, whereas 
there was no change in the HFpEF group (Figure 4.3B). The relative heterogeneity of LV 
strain, reflected by the coefficient of variation among regional strains, more than doubled 
in the HFrEF group by 28 days but remained unchanged in the HFpEF group 
(Figure 4.3B).  
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4.4.2 Inverse Estimation of Regional Stiffness Indices 
For each case, the pattern search optimization algorithm was initiated, and the 
relative error in regional strain, mean wall thickness, and LV area was quantified through 
the objective function (𝛱) for each set of stiffness indices defined by the algorithm. A 
global minimum of the objective function was reached through iterative refinement of the 
stiffness indices for all cases with an average convergence time of 48.6±3.4 minutes. The 
minimum objective function values obtained for the HFrEF group at both 14 days and 28 
days were found to be significantly elevated relative to baseline values (𝛱=11.8±1.4 
(baseline) vs. 𝛱=28.3±7.7 (14 days) and 𝛱=35.3±6.9 (28 days), p<0.05). In contrast, 
insignificant changes in the obtained minimum objective function values were observed in 
the HFpEF group between baseline and 28 days. Elevated objective function values in the 
HFrEF group are an expected consequence of the increasingly heterogeneous wall 
geometry and mechanical behavior associated with the induced LV remodeling. 
Changes in myocardial passive stiffness of the HFrEF group exhibited obvious 
regional dependence, exemplified at 28 days by the nearly order-of-magnitude higher 
stiffness index in the infarcted apical anterior region as compared to the remote 
myocardium (80.6±14.9 vs. 8.6±2.7) (Figure 4.4A). The global stiffness index, defined as 
the spatial-average of the passive regional stiffness indices, reached a maximum at 14 days 
in the HFrEF group and remained elevated relative to baseline at 28 days (Figure 4.4B). 
While changes in the global stiffness index in the HFpEF group were attenuated in 
comparison to the HFrEF group, a greater than three-fold increased relative to baseline was 
observed at 28 days. The relative heterogeneity of stiffness, taken as the coefficient of 
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variation among regional stiffness indices, was significantly elevated in the HFrEF group 
relative to both baseline and the HFpEF group at both 14 and 28 days (Figure 4.4B). 
4.4.3 Myocardial Wall Stress 
Subsequent simulations that incorporate the identified local stiffness indices 
allowed for quantification of the 1st principal stress field at end-diastole. At both 14 and 28 
days, the maximal regional stress observed in the HFrEF group was coincident with the 
location of the ischemic injury, while a qualitatively more uniform stress distribution was 
observed in the HFpEF group (Figure 4.5A). The global 1st principal stress, defined as the 
spatial-average of 1st principal stress, was elevated relative to baseline in both groups at 14 
and 28 days, with significantly higher stresses in the HFrEF group compared to the HFpEF 
group (Figure 4.5B). 
4.4.4 Correlation Analysis 
A correlation matrix was developed for each group to relate established indices of 
global function and geometry to computed biomechanical indices (Figure 4.6). In the 
HFrEF group, global LV longitudinal strain positively correlated with LVEF and 
negatively correlated with LV volume and LA area. Inverse relations were observed when 
these indices were correlated with global stiffness index and global 1st principal stress. 
Conversely in the HFpEF group, there was no correlation between global LV longitudinal 
strain and LV ejection fraction, volume, or LA area. Notably, LA area, an index of 
progressive HF, exhibited strong positive correlations with the computed global stiffness 
index and global 1st principal stress in both the HFrEF and HFpEF groups. 
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4.5 DISCUSSION 
The structural and functional milestones for the development and progression to 
heart failure (HF) are changes in LV structure and function – commonly termed myocardial 
remodeling. This process is manifested at the regional myocardial level, and thus, 
approaches which can identify and be sensitive to changes in regional myocardial 
mechanics would allow for early detection in patients at risk for HF progression. While 
past studies using magnetic resonance imaging and post-processing algorithms have 
identified the potential relevance of assessing regional mechanics in patients with 
developing HF, this approach can be problematic. Firstly, this imaging approach is not 
amenable to point-of-care application and analysis. Secondly, this imaging approach is not 
readily amenable to repeated, serial measurements in terms of screening and identifying 
HF progression. Accordingly, the major significance of this study was to put-to-practice a 
methodology and framework to quantify myocardial mechanical properties based on post-
processing of typically available echocardiographic data.  
While HF is a term which applies to the spectrum of symptoms, it is important to 
phenotype the underlying HF process. In that regard, it is now recognized by consensus 
that HFrEF and HFpEF are two distinct phenotypes, with differing etiologies, trajectories 
to HF, and, most importantly, distinctly different forms of LV dysfunction. To that end, we 
developed a novel approach to quantify myocardial mechanical properties and applied it to 
relevant large animal models of HFrEF and HFpEF. Our results demonstrated the utility of 
this approach in terms of serial measurements and revealed distinctly different patterns of 
regional myocardial mechanical changes in HFrEF and HFpEF. This work underscores the 
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need for sensitive assessments of LV regional mechanical performance to identify the 
development and progression of these HF phenotypes. 
4.5.1 Building Upon Prior Studies 
Even though the present study developed a regional LV stiffness index which is 
unique to this study, relative comparisons to other studies can be made. Specifically, 
elevations in the LV stiffness index with HFrEF, which peaked at 14 days post-MI, reflect 
similar trends in mechanical property indices reported in both in-vivo and ex-vivo 
studies.57,76,79,81,122,175 Furthermore, the more progressive increases in this LV stiffness 
index with HFpEF is in agreement with observations made in both small and large animal 
models of LV pressure overload-induced hypertrophy.18,132,133,176 However, it should be 
emphasized that the increased LV stiffness index in both HFrEF and HFpEF does not imply 
similar biological or physiological underpinnings. Specifically, in HFrEF secondary to MI, 
the predominant contribution to the increased global LV stiffness index was contained 
within the MI regions; reflective of scar formation and collagen accumulation. Contrarily 
in HFpEF, the LV stiffness index was due to a more global shift; reflective of the more 
diffuse collagen accumulation (i.e. fibrosis).  The present study demonstrated that these 
distinctly different patterns of LV myocardial stiffness could be identified in both a spatial 
and temporal fashion. 
4.5.2 Clinical Translation 
The approaches applied to these preclinical large-animal models was then put-to-
practice in terms of deployment as a complete software application (Figure 4.7A) using a 
de-identified transthoracic echocardiographic study (privacy policies set forth by the 
Department of Veteran’s Affairs Cooperative Studies) of a patient with defined HFpEF 
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(i.e. elevated LV filling pressure and LA enlargement). Using the methodological 
approaches described herein, the heterogeneous distribution of stiffness indices and 
1st principal Cauchy stress was computed (Figure 4.7B-D). As presented, this technology 
can be directly translated into a clinical setting as a complement to current standard-of-care 
echocardiography studies.  
4.5.3 Future Directions 
While this proof-of-concept study was completed on a workstation as a post-
processing step for previously acquired images, it is feasible to translate this methodology 
to a server or cloud-computing framework to allow for direct incorporation into standard 
echocardiography machines. The FE solver and optimization algorithm employed in this 
study utilize parallelization of computational cores. Therefore, incorporating this 
framework into a many-threaded computational platform will drastically improve 
computational time – increasing the likelihood of translating this analysis in a clinical 
setting.162 Furthermore, it is reasonable to assume an evolution of this technology which 
bypasses the inverse FE optimization all-together. Once this technology has been applied 
to enough cases, there will be a large library of evidence detailing the dynamic interplay 
between regional passive mechanical property changes and various forms of heart disease. 
A future evolution of this technology could be developed as a form of artificial intelligence 
informed by a supervised machine learning algorithm to predict the evolution of regional 
myocardial stiffness and stresses for a given patient based on the body of evidence 
previously collected from other patients. 
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4.5.4 Methodological Limitations 
The present study demonstrates that an inverse methodology can be reasonably 
performed to estimate the passive mechanical properties of the LV myocardium relevant 
to a clinical context. However, several methodological limitations must be considered. 
First, while our results are in qualitative agreement with previously reported findings, in-
vivo quantification of mechanical properties should be validated against results obtained 
from ex-vivo mechanical testing and modeling. Furthermore, given the inherent mechanical 
nonlinearity of the myocardium, the resultant passive stiffness indices refer only to a 
specific (low pressure) component of the overall myocardial mechanical response. 
Additionally, prior studies have shown shifts in the predominant collagen fiber orientation 
and undulation as a consequence of disease progression and relative position in the 
LV.34,177 While this study assumes a constant fiber angle on the longitudinal-radial plane 
and a constant degree of fiber undulation, future iterations of the model will incorporate 
these known variations. Finally, the model is limited to two-dimensions and exhibits 
sensitivity to the applied boundary conditions. Future work will be focused on translating 
this framework to three-dimensions and the application of increasingly realistic boundary 
conditions. 
4.5.5 Conclusion 
The methods and framework proposed herein promote passive myocardial 
mechanical property identification, and therefore could help evaluate the rate and extent of 
LV remodeling in the context of heart disease. This type of noninvasive, point-of-care 
analysis has the potential to significantly improve cardiovascular disease diagnostics and 
inform clinicians and researchers on patient-specific disease progression. 
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4.7 TABLES 
Values are means ± SE. * p<0.05 vs. the respective baseline value. (LVEF: left ventricular 
ejection fraction; EDV: end diastolic volume; BW: body weight; LA: left atrium) 
Table 4.1: Echocardiographic estimation of indices of left ventricular geometry 
and function 
Treatment Day LVEF (%) EDV/BW (mL/kg) LA Area (cm2)
Baseline (17) 0 64.6 ± 1.3 1.6 ± 0.1 6.2 ± 0.3
HFrEF (8)
14 37.8 ± 2.3* 2.8 ± 0.2* 10.1 ± 0.4*
28 37.5 ± 3.4* 2.6 ± 0.2* 11.0 ± 0.4*
HFpEF (9)
14 63.8 ± 1.0 1.6 ± 0.2 9.9 ± 0.5*
28 66.1 ± 1.0 1.5 ± 0.1 11.3 ± 0.5*
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4.8 FIGURES 
 
Figure 4.1: Formulation of the finite element mesh. 
(A, D) At both end-systole and end-diastole, quantitative strain analysis was performed 
on LV long-axis echocardiographic images. (B, E) Epicardial, mid-myocardial, and 
endocardial nodes were defined from the mid-myocardial strain analysis position data 
and regional thickness measurements. (C, F) A eight-node trilinear hexahedral FE mesh 
was formulated with two elements spanning the distance between each of the mid-
myocardial nodes and eight elements spanning the distance between the pairs of 
endocardial and epicardial nodes 
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Figure 4.2: Inverse methodology to identify mechanical properties from STE. 
(A) From the echocardiographic cine loops, mid-myocardial position data, regional wall 
thickness, and estimations of PCWP were acquired. A FE model is generated from the 
initial end-systolic geometry and boundary conditions are defined for two quasi-static 
simulation steps. An initial guess for the regional stiffness indices is defined and the 
converged solution was attained from a PARDISO linear FE solver. (B) The objective 
function (𝛱) value is determined and evaluated against the stopping criteria. If stopping 
criteria is not met, regional stiffness indices were re-defined from the pattern search 
optimization algorithm. After the stopping criteria is satisfied, a final regional 
distribution of stiffness indices is acquired, and end-diastolic longitudinal and radial 
stress are calculated. The pattern search optimization algorithm iteratively explored 
combinations of regional stiffness indices until a minimum value of the objective 
function (𝛱) was attained. As the objective function is minimized, the regional strain 
computed from the FE model converged upon the experimentally measured regional 
strain. 
(A) (B)
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Figure 4.3: Changes in peak longitudinal strain throughout disease progression. 
(A) Spatial maps of the absolute value of the peak LV longitudinal segmental strain 
determined directly from quantitative STE were generated for each of the two study 
groups at baseline as well as 14 and 28 days after the onset of disease. (B) The global 
LV longitudinal strain, taken as the fractional change in the total length of the LV cross-
section, was determined for each subject over time. The relative heterogeneity of strain, 
taken as the coefficient of variation between each of the regional measurements, was 
determined for each subject over time. * p<0.05 vs. respective baseline value; + p<0.05 
vs. respective HFpEF value. 
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Figure 4.4: Dynamic changes in regional mechanical stiffness throughout disease 
progression. 
The inverse method of identifying mechanical properties was applied to each subject at 
baseline as well as 14 and 28 days after the onset of disease. (A) Representative cases 
of both heart disease models demonstrate heterogeneous regional changes in 
mechanical stiffness as the disease progresses. (B) The spatially-averaged global 
stiffness index was determined for each subject over time. Additionally, the relative 
heterogeneity of stiffness, taken as the coefficient of variation for each subject, was 
determined for each subject over time. * p<0.05 vs. respective baseline value; + p<0.05 
vs. respective HFpEF value. 
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Figure 4.5: Determination of end diastolic myocardial wall stress. 
The 1st principal stress throughout the myocardium was computed for each subject at 
baseline as well as 14 and 28 days after the onset of disease. (A) Representative cases 
of both heart disease models demonstrate the spatial variance of 1st principal stress and 
the extent to which this is altered throughout the progression of the disease. (B) The 
spatial-average of 1st principal stress (i.e. global 1st principal stress) was determined for 
each subject over time. * p<0.05 vs. respective baseline value; + p<0.05 vs. respective 
HFpEF value. 
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Figure 4.6: Correlation between biomechanics and global indices of geometry and 
function. 
A Pearson correlation was used to interrelate standard echocardiographic response 
variables (LVEF, EDV/BW, and LA Area) with patient-matched changes in 
biomechanical response variables (GLS, GSI, and Stress) in each disease model. 
* p<0.05 for the Pearson correlation coefficient (ρ). (LVEF: left ventricular ejection 
fraction; EDV: end-diastolic volume; BW: body weight; LA: left atrium; GLS: global 
LV longitudinal strain; GSI: global stiffness index; Stress: spatial-average of 1st 
principal stress) 
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Figure 4.7: Clinical translation of methodology. 
(A) This methodological process was compiled within a novel software application 
designed for clinical use and applied on transthoracic echocardiographic images 
obtained from a human subject. Quantitative strain analysis was performed, (B) a FE 
mesh was generated from the end-systolic geometry, and (C) the inverse method of 
identifying mechanical properties was applied to identify a distribution of stiffness 
indices. (D) Post-processing of the FE results allows for the calculation of first principal 
stress at end-diastole. 
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CHAPTER 5 
THESIS SUMMARY AND CONCLUSION 
5.1 MAJOR CONTRIBUTIONS TO THE FIELD 
The seminal principal of biomechanics is the fact that the structure and function of 
a given tissue is a consequence of its mechanobiological environment. As the incidence of 
heart failure continues to rise along with the aging population in the United States, a 
comprehensive understanding of the mechanobiological factors that influence the 
progression of the disease will be of vital importance. To that end, we employed a multi-
disciplinary approach to study the dynamic interplay between myocardial geometry, the 
collagen microstructure, mechanical behavior, and mechanical properties in response to 
both myocardial infarction and left ventricular pressure overload. The significant and 
noteworthy contributions to the field were two-fold. First, we pioneered a non-invasive 
approach to quantify the mechanical properties of the LV myocardium using STE. We 
accomplished this first through the use of stress-strain relations and a modified thick-
walled ellipsoid model. We then improved upon this with an inverse finite element 
framework to identify the heterogeneous field of mechanical properties for both large 
animal models of heart failure. This work was put to practice in a prospective analysis of a 
HFpEF patient after deployment of the methodology into an all-inclusive software 
package. Second, in both models of heart failure, we identified potential therapeutic targets. 
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Our analysis of the mechanical properties in the post-MI LV (Chapter 2) showed a 
significant drop in mechanical stiffness in the non-viable MI region between 14- and 28-
days post-MI and increases in the stiffness of the viable remote myocardium over that same 
period of time. These observations were coincident with increases in end diastolic volume 
and LV filling pressure. While it is difficult to discern cause-and-effect relationships 
between structural and mechanical changes, these findings underscore the potential 
therapeutic benefits of mechanically stabilizing the MI region early in the remodeling 
process (e.g. with biomaterial injections). Furthermore, the correlative analysis performed 
between microstructural changes and mechanical changes in the pressure-overloaded LV 
(Chapter 3) revealed that the reorganization of the microstructure further modulates the 
increase in mechanical stiffness late in the remodeling process. Specifically, we observed 
a reduction in fiber undulation and preferential orientation in the circumferential direction 
that resulted in elevated passive stiffness of the myocardium. Future work focused on 
limiting this microstructural reorganization could potentially improve diastolic filling by 
restoring the native compliance of the LV. 
5.2 FUTURE WORKS 
The immediate future of these works is to expand upon the multi-photon SHG 
imaging and inverse finite element analysis approach to develop a structure-motivated 
platform to identify the constitutive properties of the post-MI LV. We have performed an 
initial analysis of the collagen structure in the MI region three (n=3), seven (n=3), 14 (n=4), 
and 28 (n=3) days post-MI from a porcine model of left anterior descending artery ligation 
along with a cohort of referent control samples (n=3) (Figure 5.1A). Three-dimensional 
analysis of the collagen fiber network showed a relative increase in frequency of lower 
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values of undulation in all three layers studied as early as three days post-MI. This trend is 
shown to peak at 14 days post-MI which coincides with the time at which the infarcted 
myocardium has been shown to reach peak passive mechanical stiffness.81,122 Furthermore, 
this analysis confirms previously reported claims that collagen fibers become more 
circumferentially aligned after MI with the majority of fibers found to be within 
approximately 20° of the circumferential axis at 28 days post-MI.34 The azimuthal fiber 
angle and undulation in each of the epicardium, mid-myocardium, and endocardium has 
been incorporated into a multi-layered finite element model of the two-dimensional LV 
(Figure 5.1B). A modification of the framework introduced in Chapter 4 will be applied 
to these models so as to allow for the identification of the full set of parameters of the 
transversely-isotropic Mooney-Rivlin constitutive model. Furthermore, this analysis will 
shed further light on the extent to which the reorganization of the microstructure influences 
the passive mechanical properties of the post-MI LV. 
Furthermore, while the work presented in Chapter 4 specifically relates to the LV, 
the same methodology can be extended to other soft tissues within the body. This extension 
would be contingent on two factors: (1) access to an image modality which would allow 
for the successful tracking of the tissue deformation in response to a given load and (2) an 
accurate estimation of the in-vivo load exerted on the tissue. Candidate applications of 
potentially high clinical value include assessment of thoracic or abdominal aortic 
aneurysms. First, the irregular geometries of these structures negate the use of analytical 
approaches to identify constitutive model parameters and challenge the quantification of 
wall stress distributions. Furthermore, STE and magnetic resonance have been previously 
applied to track aortic deformation during and after ventricular ejection.178,179 Finally, 
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doppler echocardiography can be used to generate a reasonable estimation of aortic 
pressure.180 Given the fact that surgical repair of aortic aneurysms carries a mortality rate 
approaching 10%,181 this detailed mechanical analysis would provide surgeons with 
complimentary data for patient risk stratification and surgical decision making.   
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5.3 FIGURES  
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Figure 5.1: Structure-motivated model enables a transient analysis of the 
heterogeneous mechanical properties of the post-MI left ventricle. 
(A) Regional undulation was computed for the epicardial, mid-myocardial, and 
endocardial sections of the MI region. Elevation angle, ϑ, was computed from the 
circumferential-longitudinal plane. An angle of ϑ=0° is defined as a fiber perfectly 
aligned with the circumferential axis. Azimuthal angle, φ, was computed from the 
longitudinal-radial plane. An angle of φ=0º is defined as a fiber perfectly aligned with 
the radial axis. (B) Two-dimensional computational models were generated from 
echocardiographic images with spatial discretization of the remote myocardium (blue), 
border zone (orange), and the MI region (red). Future inverse finite element analysis 
will allow for the identification of the full set of parameters of the transversely-isotropic 
Mooney-Rivlin constitutive model.  
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